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A COMPARITIVE STUDY OF MICROALBUMINURIA BETWEEN 
PREHYPERTENSIVE AND NORMOTENSIVE INDIVIVIDUALS 
ABSTRACT 
BACKGROUND: 
                 The aim of the study is to look for the presence of 
microalbuminuria in two groups namely a prehypertensive group (BP 120-
139/80-89mmHg) and a normotensive group (BP <120/80mmHg) and to 
find out is there a significant difference in presence of microalbuminuria in 
both groups. Also to look for the other end organ damage such as diastolic 
dysfunction and fundus changes and to find out is there a significant 
difference in both the groups. 
METHODS: 
               The study participants who were selected from ward patient’s 
attenders were divided into two groups based on their blood pressure 
measurement.  A brief history was recorded. Urine albumin creatinine ratio 
for microalbuminuria, fundus examination for retinopathy and 
echocardiogram to detect diastolic dysfunction was done in all participants. 
Other relevant investigations were done. 
RESULTS: 
              The distribution of microalbuminuria in two groups are 2% and 
28% in normotensive and prehypertensive group respectively (‘p’ value 
is<0.001) which is statistically significant. The distribution of diastolic 
dysfunction is 32% in prehypertensive group while none had diastolic 
dysfunction in normotensive group (‘p’ value is 0.004) which is statistically 
significant. 60% of those participants with microalbuminuria had associated 
diastolic dysfunction also. 
CONCLUSION: 
              End organ damage starts to occur even at a prehypertension stage of 
blood pressure. So screening for high BP should start early and if detected to 
be prehypertensive, life style modification should be strongly recommended. 
KEY WORDS: Prehypertension, Normotension, Microalbuminuria, 
Diastolic Dysfunction, Hypertension, End Organ Damage. 
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INTRODUCTION 
          Prehypertension  is  a  blood  pressure  reading  where the  patient‘s 
BP is more  than  normal but  not  up to the level  which is  considered  as 
hypertension. Prehypertension is a warning sign that the patient may develop 
hypertension in his near future. According to American Heart Association, 
around 59 million people are having prehypertension in United States. 
        The NHANES(The  National  Health And Nutrition Examination 
Survey) which is a  part  of  National  Center  for  Health Statistics  (NCHS), 
located within CDC  (Center for Disease Control and  Prevention) was 
conducted in the year 1999 and 2000. The data obtained from this survey 
showed that around 31 percent of people in United States had 
prehypertension
[1]
. The prevalence was 39 percent among men and 23 
percent among women
[2]
. 
        NHANES( 1999-2000) also found that almost 29% of the adult non 
institutionalized U.S. population, which is an estimated 58.5 million 
individuals, had hypertension , with systolic BP of >=140 mm Hg and 
diastolic BP of  >=90 mm Hg. The prevalence has increased by 3.7% 
compared with the previous NHANES data from 1988 to 1991.
 
NHANES     
[9] 
 
(2011-2012) had found that the prevalence of hypertension was 29.1 percent 
which is almost similar to that in 1999-2000.  
         Based on classification proposed by JNC 7, prehypertension is termed 
as a person‘s BP falling within the range  of  systolic blood pressure (120-
139 mmHg)  and diastolic  blood pressure  (80-89) . The person is said to be 
hypertensive if his BP falls in the range of systolic BP (>= 140 mmHg) and 
diastolic BP (>=90mmHg)
[4] 
 
               Prehypertensive individuals are usually asymptomatic. They don‘t 
come to the clinicians unless they are symptomatic either due to end organ 
damage  or symptoms  due  to elevated  blood  pressure  or  coming to 
clinicians due to some other problems. But the prehypertensive  individuals  
are  always  at  risk  of progression to overt hypertension if left undetected. 
[10] 
 
              Hence screening and identification of prehypertensive individuals 
becomes utmost important. 
              The prevalence of prehypertension in India has been found to be 
32%. The study was done on a urban population in central India. Another 
study showed that the prevalence of prehypertension was around 36 percent 
in Chennai and 44 percent in Delhi
[24]
.  
RISK FACTORS AND ASSOCIATION OF PREHYPERTENSION: 
 Many studies have found that prehypertension is more common in males 
than in females
[60]
 and in some studies it has shown that its prevalence is 
more common than hypertension itself. 
 Prehypertension is more prevalent in diabetics than non diabetics. When 
both coexist together, the cardiovascular risks is considerably higher. 
 The prevalence of metabolic syndrome is more in prehypertensives than in 
normotensives
[59]
. 
 The prehypertensives tend to have higher levels of low density lipoprotein, 
triglycerides and lower levels of high density lipoproteins when compared to 
normotensive individuals.
[58]
 
 The waist circumference and body mass index are considerably higher in 
prehypertensives than normotensives 
[11] 
 
 Prehypertensives has higher levels of C-reactive protein[62], tumour necrosis[ 
factor- alpha
[63]
, homocysteine leves and white cell count when compared to 
normotensives 
 Prehypertensives also have higher levels of uric acid and ferritin when 
compared to normotensive individuals.  
PROGRESSION TO HYPERTENSION: 
           In Framingham Heart Study, the rate of progression of 
prehypertension to hypertension was studied. It was found that the rate of 
progression was 19% over a period of 4 years
[61]
. One more related study, 
showed that the progression was 40% over a period of 2 years. The rate of 
rise depends on the age and BP of that individual. 
            Those with BP in the range of 130-139/85-89mmHg, has a 
progression rate of 43% over a period of 4 years when compared to those in 
the lower BP range that is BP of 120-129/80-84mmHg  who has a 
progression rate of 20% over a period of 4 years. In accordance with the age, 
those in the age group of 65 years and above progresses from 
prehypertension to hypertension at a rate of 42% when compared to lower 
age group whose progression rate was 27%
[61]
.  
 
[12] 
 
 
CARDIOVASCULAR RISK AND PREHYPERTENSION:  
         Since there is higher prevalence of  C-reactive protein, homocysteine, 
uric acid and other inflammatory markers in the prehypertensive group the 
risk of acquiring a cardiovascular problem is more common in the 
prehypertensive individuals than the normotensive individuals. The Jichi 
Medical School Cohort Study Of Japan found that prehypertensive 
individuals are at a 45% higher risk of having a cardiovascular event over a 
period of 10 years when compared to normotensive individuals
[64]
. 
TARGET ORGAN DAMAGE AND PREHYPERTENSION: 
            In a study done in Sungkyunkwan University School of Medicine in 
Korea, the presence of microalbuminuria was done in prehypertensive 
individuals. The prehypertensive individuals are divided into two groups as 
BP in the range of 130-139/85-89mmHg and BP of 120-129/80-84mmHg. 
The study showed that presence of microalbuminuria is significantly higher 
in the higher BP group individuals
[66]
. In another chinese study the presence 
of microalbuminuria was found to be higher in prehypertensive group than 
in normotensive group. In the same study the levels of serum uric acid was 
found to be higher in prehypertensive people than the normotensive 
[13] 
 
people
[65]
. Also the cardiovascular risk is higher in the group with 
microalbuminuria.  
                    In a study published in pubmed which was done in Turkey, the 
diastolic dysfunction was assessed in prehypertensive individuals. The 
diastolic dysfunction was assessed using various parameters. The result was 
diastolic dysfunction was higher in prehypertensives than normotensives
[67]
.  
                    In another study done in another institution in Turkey published 
in pubmed, apart from diastolic dysfunction, the degree of aortic stiffness is 
also measured using ultrasonography. It was found that both are 
comparatively higher in prehypertensive individuals and also C – reactive 
protein was measured in these individuals which showed a higher levels of 
C- reactive protein in those with end organ damage
[68]
.  
                     In a study done in a School Of Medicine in Greece which was 
published in the Journal of American Heart Association, they compared the 
common carotid artery intima media thickness and left ventricular mass in 
25 prehypertensive individuals and 25 normotensive individuals. It was done 
to test subclinical atherosclerosis and target organ damage in heart. The 
study concluded as prehypertensive individuals had a higher intima media 
[14] 
 
thickness and left ventricular mass when compared to normotensive 
individuals. 
               In all these studies, the ultimate result is that subclinical target 
organ damage is more common in prehypertensive individuals than 
normotensive individuals. Also those with target organ damage have a faster 
progression to overt hypertension. Hence the prehypertensive individuals are 
the risky individuals who are not addressed often and usually less considered 
when compared to overtly hypertensive individuals. So screening 
prehypertensive individuals also becomes important and lifestyle 
modifications should be initiated even at that level of BP. 
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AIM OF THE STUDY 
PRIMARY OBJECTIVES: 
               To look for the presence of microalbuminuria in the both the 
groups (prehypertensive group and normotensive group) and to find out is 
there a significant difference in presence of microalbuminuria in both 
groups.  
SECONDARY OBJECTIVES: 
 To look for the presence of target organ damage in both groups such as 
fundus changes and diastolic dysfunction. 
 To look for association of prehypertension with factors like age, sex, 
smoking, alcohol consumption. 
 To look for association of microalbuminuria with various factors like age, 
sex, smoking, alcohol consumption in both groups. 
 To look for association of fundus changes and diastolic dysfunction with 
factors like age, sex, smoking and alcohol consumption in both groups. 
 To look for association of microalbuminuria with fundus changes and 
diastolic dysfunction in both groups.                                                                                                                  
                                                                     
[16] 
 
REVIEW OF LITERATURE 
                        The arterial blood pressure is a measure of the potential energy of 
arterial wall or lateral force per unit area of vascular wall. It is usually 
expressed in units of dynes per cm
2
. But clinically the measurements of 
arterial pressure are usually made by mercury manometer. It is expressed in 
mmHg. 
             1 mmHg = 1.332 dynes/cm
2
 i.e. 120/80 mmHg = 160/106.5 dynes/cm
2 
          COMPONENTS OF BLOOD PRESSURE: 
1. Systolic Blood Pressure:  It is the amount of maximum pressure exerted 
during systole. It indicates the amount of work done by the heart or force 
with which the heart is working. It also indicates the degree of pressure that 
the arterial walls have to withstand 
2. Diastolic Blood Pressure: It is the minimum pressure that is exerted during 
diastole of cardiac cycle. It measures the total peripheral resistance. It also 
indicates the constant load against which the heart has to work 
3. Pulse pressure: It is the obtained when the diastolic blood pressure is 
subtracted from the systolic blood pressure. It indicates the volume of the 
pulse during each cardiac cycle   
[17] 
 
4. Mean blood pressure: It indicates the average blood pressure that is present 
throughout the cardiac cycle.                                                                                                                                                                                                                                                                                                                                                                                     
Mean blood pressure = diastolic blood pressure + 1/3 pulse pressure 
The blood flow to each organ depends on the mean arterial blood 
pressure. Normal mean arterial pressure is 95- 100 mmHg 
5. Proportional pulse pressure: It is obtained when the pulse pressure is divided 
by the systolic blood pressure and is measured in percentage. 
Proportional pulse pressure = pulse pressure /systolic blood pressure * 100%  
If it is < 25% then it identifies 90% of patients with systolic failure and a 
cardiac index of < 2.2 L/min/m
2 
( normal cardiac index – 2.6 to 4.2L/min/m2)   
DETERMINANTS OF ARTERIAL BLOOD PRESSURE: 
 Arterial BP is the product of cardiac output (CO)  and  peripheral 
resistance(PR) so, BP = CO * PR. 
 Cardiac output is calculated by multiplying heart rate (HR) and stroke 
volume (SV) 
 CO = HR* SV 
 If the increase in CO is due to increase in SV, then it is the systolic blood 
pressure which increases. 
 If the increase in CO is due to increase in HR, then it is the diastolic blood 
pressure which increases. 
[18] 
 
 If the increase in CO is due to both increase of CO and HR, both the systolic 
and diastolic blood pressure increases. 
 The peripheral resistance is determined mainly by the arterioles and it 
depends on four factors, 
1. Elasticity of the vessel wall 
2. Velocity of the blood flow 
3. Viscosity of the blood 
4. Total blood volume in the arterial system 
    HISTORY: 
                      Stephen Hales was the first person to measure blood pressure. In 
1733 he first recorded it on a horse. He inserted a long tube vertically 
upwards into an artery and observed the raise in pressure as the blood 
column was forced up the tube by the movement of the blood in the artery
[3]
. 
The first sphygmomanometer was invented in 1881 by Samuel Siegfried 
Karl Ritter Von Basch
[5]
. It had a rubber bulb that was filled with water 
which restricted the blood flow in the artery. The bulb was connected to a 
mercury column that translated the pressure into millimeters of mercury. 
                         In 1896 further improvement was done by Scipione Riva- Rocci. 
He first introduced the cuff that would be applied around the limb for 
[19] 
 
compressing the artery. He was the one who designed the prototype for the 
present day instrument
[6]
. Until 1905, BP was measured using palpatory 
method only after which it was  Nikolai Korotkoff
[7]
, a Russian surgeon who 
introduced the Korotkoff sounds which includes five phases, the  appearance 
and disappearance of the sounds corresponding to the systolic and diastolic 
blood pressure respectively. This method was known as auscultatory method  
of recording  BP. 
           Currently the various methods available for the measurement of BP includes 
1. Sphygmomanometric measurement : palpatory and auscultatory method 
2. Doppler ultrasound method 
3. Oscillometric method 
4. Self measurement (home BP recording) 
5. Ambulatory BP monitoring 
    PROPER TECHNIQUE FOR BP RECORDING: 
                    The width of the cuff should be 40% of the limb circumference and 
the length of the cuff should be 80% of the limb circumference
[4]
. The ratio 
between width and length of the cuff should be 1:2. The standard cuff size 
available and we are commonly using size is a width of 5 inch and a length 
of 10 inch. 
[20] 
 
                      If this standard cuff is applied to a larger arm as in obese individual 
or a normal adult thigh, the BP is overestimated and if the same cuff is 
applied to a smaller arm the BP is underestimated. 
                     In patients with arteriosclerosis, the systolic BP can be overestimated 
as high as 30mmHg. The cuff width should be 1.5 inch in infants and small 
children, 3 inch in older children and 8 inch in obese individuals. 
                    Before recording the patient should avoid caffeine, exercise and 
smoking at least 30 minutes before measurement. The patient should be 
seated quietly and comfortably for at least 5 minutes in a chair. His/hers arm 
should be supported at the heart level and feet on the floor. Cuff should be 
applied over the artery at the level of heart and the lower edge of cuff should 
be at least 1 inch above the antecubital fossa.  
                    BP recording to be done both by palpatory and auscultatory method 
and the cuff should be deflated rapidly. A complete one minute should 
elapse before recording the BP in the same limb. If the cuff is elevated 
before that it may artificially elevate the diastolic BP. Ideally BP recording 
should be done in both upper limb and at least one lower limb. 
 
 
[21] 
 
     PHYSIOLOGY OF BLOOD PRESSURE: 
           There are five physiological mechanisms which is responsible for 
maintaining blood pressure within normal range. 
1. Response of the autonomic nervous system 
2. Capillary fluid shift mechanism 
3. Role by kidney and fluid balance mechanism 
4. Hormonal actions 
5. Local regulatory factors 
a) AUTONOMIC NERVOUS SYSTEM: 
                    A drop in blood pressure which may be secondary to decreased 
cardiac output will be sensed by the baroreceptors located in carotid sinus 
and aortic arch
[11]
. This sends signals to the vasomotor center located in 
brain so that efferent signals are sent that lead to sympathetic nervous 
system activation that in turn leads to adrenaline and noradrenaline release.  
           The response to this stimulus is achieved through alpha and beta receptors 
 Alpha receptor stimulation leads to adequate perfusion in essential territories 
like cerebral and coronary vascular beds. But it may lead to hypoperfusion 
of less essential vascular bed because of increased vascular resistance and 
afterload can lead to decreased cardiac output 
[22] 
 
 Beta receptor stimulation leads to stimulation of adenylyl cyclase which 
increases the levels of cyclic AMP. This lead on to positive chronotropic, 
inotropic and lusiotropic effect that results in increase in heart rate, increase 
in force of contraction and improved diastolic relaxation respectively. It also 
stimulates the release of renin from juxta glomerular apparatus (JGA).  
b) CAPILLARY FLUID SHIFT MECHANISM: 
According to Starling Hypothesis, there is a fluid exchange happening at 
capillary level that is determined by hydrostatic and oncotic pressure. Higher 
hydrostatic pressure in blood and decreased oncotic pressure in interstitium 
shifts the fluid out of intravascular compartment. Lower hydrostatic pressure 
and increased oncotic pressure in interstitium shifts the fluid into 
intravascular compartment. In hypotensive states , the interstitial fluid enters 
into intravascular compartment leading fluid expansion in vessel and thus 
increased BP. 
c) KIDNEY AND FLUID BALANCE MECHANISM: 
In addition to the RAAS system, blood pressure is regulated by:  
 Pressure Diuresis: As the blood pressure increases, the flow through the 
kidneys also increases and this increases glomerular filtration rate and hence 
urine output and decreased fluid volume. 
[23] 
 
 Pressure Natriuresis: Increased renal perfusion pressure result in increased 
sodium excretion.  If more sodium is excreted less water is reabsorbed and 
hence the extracellular fluid volume decreases thereby decreasing BP
[12]
.
 
d) HORMONAL ACTIONS: 
           JGA maintains BP through Renin -Angiotensin -Aldosterone System 
(RAAS). Renin is released by Juxta Glomerular cells through various stimuli 
which include: 
1) Baroreceptors located in afferent arteriole stimulated by drop in renal blood 
flow. 
[24] 
 
2) Decreased delivery of sodium chloride to distal tubule which is sensed by 
the macula densa, a chemoreceptor like action 
3) Beta receptor mediated release of renin by the release of adrenaline as 
sensed by the carotid sinus and aortic arch baroreceptors. 
           Renin is aspartyl protease which is synthesized as an inactive 
precursor, prorenin. Most of the renin in circulation is synthesized by the 
juxta glomerular cell located in the afferent arteriole. Prorenin is secreted 
directly into the circulation or it may be activated inside the secretory cells 
and released as active renin
[13]
. Plasma contains two to five times more 
amount of prorenin than renin but there is no evidence that prorenin has 
physiological activity.  
                     
          
[25] 
 
                            Renin breaks down Angiotensinogen which is produced by the liver to 
Angiotensin I which is further converted to Angiotensin II by the 
Angiotensin Converting Enzyme (ACE). This action occurs at lungs. 
Angiotensinogen is an alpha 2 globulin and it is a member of serpin family. 
Its levels are increased by plasma corticosteroid, thyroid hormone and 
estrogens. It has 453 amino acids and the first 12 amino acids are required 
for its activity. 
                      ACE is secreted by endothelial cells in the vessel wall in lungs and 
kidneys. ACE apart from breaking Angiotensin I it also degrades 
bradykinin
[14][15]
. ACE has two isoenzymes. One form is the one secreted in 
the lung and kidneys and the other is the one present in brain. This brain 
ACE prevents the formation of toxic form of beta amyloid. Hence any ACE 
inhibitors used which crosses blood brain barrier may lead to progression of 
dementia. 
           Angiotensin II has half life of 30 seconds in blood and 15 to 30 minutes in 
tissues. It has the following actions: 
 It is a potent vasoconstrictor present in the body, so it directly increases the 
mean arterial pressure 
 Increases the reabsorption of sodium chloride in proximal convoluted tubule 
[26] 
 
 Increases the sensitivity of tubuloglomerular feedback 
 Stimulates the release of anti diuretic hormone (ADH) from pituitary 
 Has a prothrombotic effect through stimulation of adhesion and aggregation 
of platelets 
 Increases the synthesis and secretion of aldosterone through direct 
stimulation of zona glomerulosa of adrenal cortex. 
 Aldosterone increases sodium and water reabsorption and promotes 
potassium secretion 
 
[27] 
 
e) LOCAL REGULATORY FACTORS: 
1. Endothelin: A 21 amino acid peptide produced by endothelium result in 
vasoconstriction
[16]
. So they are secreted by endothelium they are called 
endothelins. There are three isoforms of endothelin like ET-1, ET-2, ET-3. It 
bounds to four types of endothelin receptors like ETA, ETB1, ETB2 and ETC
[17]
. 
2. Prostaglandins/prostacyclins: They are the group of hormone like 
compounds that are produced from fatty acids. They are not endocrine 
hormones but have an autocrine and paracrine action. They are two 
pathways in the synthesis of these compounds which depends on the enzyme 
with which they are produced. They are cyclooxygenase and lipoxygenase 
pathway. They include PGE2, PGF2, PGI2, PGD2, TXA2, LTA4, LTB4, LTC4, 
LTD4, LTE4. Of these compounds it is PGE2 and PGI2 (prostacyclin) are the 
ones which cause vasodilation. 
3. Nitric oxide: It is vasodilator which is synthesized in the endothelium of the 
vessel wall. It is produced endogenously (within the body) from L-arginine,   
NADPH and O2 by nitric oxide synthase enzymes. The endothelium (inner 
lining) of blood vessels make use of nitric oxide and send signals to the 
surrounding smooth muscle to relax which will produce vasodilation and 
increased perfusion to that corresponding regions. It has a halflife period 
lasting for few seconds. But it can diffuse freely across membranes. All 
[28] 
 
these factors leads to its paracrine (between adjacent cells) and autocrine  
(within a single cell) actions
[18]
. 
           Nitrate-rich vegetables, like spinach, arugula and beetroot…, have 
been found out to elevate cardioprotective levels of nitric oxide. It was also 
found to decrease the BP pre-hypertensive persons
[19]
. It maintains vessel 
homeostasis by inhibiting vascular smooth muscle contraction and growth. It 
also inhibits both platelet aggregation and adhesion of the leucocytes to the 
endothelium. Persons with atherosclerosis, diabetes mellitus or hypertension 
are found to have impaired NO pathway
[20]
. 
 
Also high salt intake tend to 
decrease nitric oxide synthesis
[21]
. Drugs like minoxidil used in hair growth, 
sildenafil citrate used in pulmonary hypertension and erectile dysfunction 
and nitroglycerine in angina all act through nitric oxide pathway. 
HYPERTENSION: 
EPIDEMIOLOGY: 
                   Hypertension arising as the major cause of burden of diseases in the 
world
[22]
. Around 76 lakh deaths and 9.2 crores disability-adjusted life years 
worldwide were caused due to increased blood pressure as per 2001. If a 
person has hypertension, the major risk of him having cardiovascular 
diseases like coronary artery disease or congestive heart failure or ischemic 
[29] 
 
and hemorrhagic stroke (CVA) or renal failure or peripheral vascular disease 
is doubled. Though antihypertensive therapy reduces some risks of 
cardiovascular and renal disease still a huge segment of hypertensives are 
either left untreated or inadequately managed. 
                     BP levels and prevalence of hypertension may vary among countries. 
In industrialized and well developed population the blood pressure may rise 
steadily for the first two decades of life. During adulthood period, average 
systolic blood pressure is higher for men than women, but among old, there 
is steeper rise for women. As a result, among individuals more than 60 years 
old, systolic blood pressure is higher for women than for men. Among 
adults, diastolic blood pressure   increases progressively up to 55 years, after 
which it decreases, leading to a wide pulse pressure beyond 60years. The 
probability for an adult or elderly to develop hypertension in his or her 
lifetime is around 90%. 
                     Recent evidences are suggesting that the prevalence of hypertension 
in India is increasing, due to increasing obesity. In African American decent, 
hypertension may appear earlier and might generally be more severe, and 
results in high rates of morbidity and mortality from its complications than 
in whites.  
[30] 
 
                    The prevalence of hypertension was estimated to be around 40.8% in 
urban and 17.9% in the rural Indian population in the year 2013. Gupta et al
 
reported the highest prevalence of hypertension (48.2%) in a recent multi-
centric study, conducted in the urban population of India
[23] 
GENETIC CONSIDERATIONS: 
                      Although there are specific genetic variants, these usually won‘t be 
applicable to more than 98% of patients having essential hypertension. For 
most people, hypertension is a polygenic disorder where a combination of 
genes acts in association with environmental factors to make a contribution 
to blood pressure.  
                    Several strategies are used to identify specific hypertension-related 
genes. Animal models often aid a powerful approach to evaluate the genetic 
loci and other related genes in association with hypertension. In these 
studies, different alleles of specific candidate genes are compared in 
hypertensives and normotensive control subjects.  
                   Current evidences suggest that genes that encode for RAAS, 
angiotensinogen and angiotensin-converting enzyme (ACE) polymorphisms, 
would relate to hypertension. Another gene that is thought to be associated 
with hypertension is the alpha-adducin gene and is thought to increase the 
[31] 
 
renal tubular absorption of sodium. Other genes possibly associated with 
hypertension may include genes coding for AT1 receptor, aldosterone 
synthase enzyme and beta2 adrenoreceptor..  
                  Some evidences also suggest that there may be genetic determinants 
available to predict target organ damage due to hypertension. Those 
evidences indicate a significant heritability of left ventricular mass and also 
any variation in genes associated with renal damage which suggests that 
some genetic factor also may play a role in hypertensive nephropathy. Some 
genetic variants have also been linked to CHD and stroke. 
                    In the future, it would be possible that DNA analysis will assess and 
identifies the individual risk for hypertension and target organ damage and 
will also identify those who respond to specific classes of antihypertensive 
agents.  
          PATHOGENESIS OF HYPERTENSION:  
                  Multiple factors contribute to the pathogenesis of hypertension apart 
from genetic and environmental considerations. Those include multiple 
system involvement, multiple hormonal involvement and multiple local 
vasoregulatory factors. 
[32] 
 
a) AUTONOMIC NERVOUS SYSTEM:   
                      Increased sympathetic activity increases blood pressure and it leads 
to the development and maintenance of high BP through stimulation of 
multiple systems like heart, blood vessels and kidneys. The net result is the 
increased cardiac output, increased peripheral vascular resistance and finally 
fluid retention
[25]
. There is an autonomic imbalance which is like high 
sympathetic tone with decreased parasympathetic tone. This is associated 
with metabolic, hemodynamic and trophic abnormalities that may finally 
result in increase in cardiovascular morbidity and mortality rates
[26]
. 
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                The mechanism that leads to high sympathetic activity in hypertension is 
complex due to changes in baroreceptor and chemoreceptors actions at both 
peripheral and central areas. Arterial baroreceptors are reset to a higher level 
in hypertensive patients and this is known as pressure resetting. There is also 
central resetting of aortic baroreflex in hypertensive patients. This pressure 
resetting seems to be mediated by angiotensin II through its central action
[27]
. 
Angiotensin II simply amplifies the response to sympathetic stimulation in 
periphery by presynaptic release of norepinephrine
[28]
.  
                          Additional mediators suppressing baroreceptor activity and 
contributing to sympathetic overactivity in hypertension include reactive O2 
species and endothelin
[29][30]
. Recently, it is also found that there is evidence 
of increased chemoreflex function, that are leading to enhanced sympathetic 
activation which occur due to hypoxia
[31]
. Clinically it can be made out by 
exaggerated increase in sympathetic activity which sustains even in the 
awake state and this also seems to be a contributory factor to hypertension in 
patients suffering with obstructive sleep apnea syndrome.  
                        Sympathetic stimulation over a long period of time induces vascular 
remodeling and hypertrophy of the left ventricle, presumably by both direct 
and indirect actions of norepinephrine on alpha and beta receptors, as well as 
[34] 
 
stimulate release of various trophic factors that includes fibroblast growth 
factors, transforming growth factor and insulin-like growth factor 1
[26]
. 
Clinical studies show positive correlations between left ventricular mass, 
circulating norepinephrine levels and reduced radial artery compliance (an 
index of vascular hypertrophy). Thus, sympathetic overactivity mechanisms 
contribute to target organ damage and hence pathogenesis of 
hypertension
[32]
. 
b) VASCULAR REACTIVITY: 
                    The vasoconstriction effect of infused norepinephrine is much higher 
in hypertensive patients than the normotensive controls. This vasoconstrictor 
response to norepinephrine is also higher in normotensive siblings of 
hypertensive parents compared to controls who don‘t have a family history 
of hypertension. All these effects suggest that the hypersensitivity may have 
a genetic origin rather than just a consequence of high blood pressure. 
                   Exposure to stress always provokes sympathetic overactivity, and if 
someone is continuously under stress, then the stress-induced 
vasoconstriction may lead to vascular hypertrophy, and hence there is an 
incremental response to peripheral resistance and blood pressure
 [33]
. This 
could partly explain why people of lower socioeconomic status have greater 
[35] 
 
incidence of hypertension, since they lead a day to day stressful life. When 
there is an associated family history of hypertension, then there is an 
augmented vasoconstrictor response and sympathetic response to lab 
stressors, like cold pressor testing and mental stress that may ultimately 
predispose them to hypertension. This is true in young Indians as well. 
Hence there is increased incidence of hypertension in patients with 
exaggerated stress responses. 
c) VASCULAR REMODELLING: 
                   In hypertension there is always an increase in peripheral vascular 
resistance due to the alterations in structure, function and mechanical 
properties of small arteries. High blood pressure and associated target organ 
damage is due to the remodeling of these vessels
[34]
. It is determined at the 
precapillary level that includes arterioles and small arteries. Increased 
resistance in hypertensive patients can be subjected to rarefaction (decreased 
number of parallel-connected vessels) and narrowed lumen of resistance 
vessels. Examination of specimens from gluteal skin biopsy of patients with 
untreated essential hypertension has uniformly revealed reduced lumen areas 
due to thickening of vessel wall and increased tunica media–lumen ratios.  
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d) ARTERIAL STIFFNESS: 
                   As age advances there is reduced elasticity (increased stiffness) of the 
large conduit arteries, hence both systolic blood pressure and pulse pressure 
increases. Arteriosclerosis as a result of collagen deposition and smooth 
muscle cell hypertrophy occurs in these arteries. There is thinning, 
fragmenting, and fracture of elastin fibers in the tunica media
[37]
. Other 
factors that contribute to a decrease in the central arterial compliance include 
estrogen deficiency, hyperhomocysteinemia, diabetes, high dietary salt 
intake and tobacco usage, by damaging the vascular endothelium. 
                  Progressive arterial stiffness increases pulse wave velocity that 
contributes to the wide pulse pressure that is commonly seen in elderly 
hypertensive patients. Younger personalities may have lower pulse wave 
velocity. Therefore we can jump into an conclusion that pulse pressure can 
be used as a single better predictor of cardiovascular disease risk rather than 
either systolic blood pressure or diastolic blood pressure per se. 
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e) RENIN ANGIOTENSIN ALDOSTERONE SYSTEM:  
                   Blood pressure is increased by angiotensin II by various mechanisms 
as described earlier in blood pressure regulation. Angiotensin II induced 
cardiac and vascular cell hypertrophy and hyperplasia occurs by directly 
activating the angiotensin II type 1 (AT1) receptor and by indirectly 
stimulating the release of various growth factors and cytokines. AT1 
receptor activation stimulates various tyrosine kinases, which in turn 
phosphorylates the tyrosine residue that occurs in several protein 
degradation, leading to vasoconstriction, cell growth proliferation
[38]
. AT2 
receptor activation stimulates a phosphatase which inactivates a mitogen-
activated protein kinase, which is a key enzyme in transducing signals from 
the AT1 receptor. Hence the action of AT1 receptor is exactly opposite to 
AT2 receptor.  
 
[38] 
 
f) ANGIOTENSIN II AND OXIDATIVE STRESS: 
                  Stimulating the oxidant production by angiotensin II is an alternative 
mechanism by which it increases cardiovascular risk. Hypertension because 
of increased angiotensin II is also found to be due to vascular p22phox 
messenger RNA (mRNA) up regulation, which is a component of the 
oxidative enzyme nicotinamide adenine dinucleotide phosphate [NADPH] 
oxidase
[39]
. The angiotensin II receptor– dependent NADPH oxidase 
activation is associated with enhanced oxidant superoxide anion formation. 
Superoxide instantly reacts with NO and forms the oxidant peroxynitrite 
(ONOO)
[40]
. Due to reduction in NO bioactivity it may provide another 
mechanism to explain the enhanced vasoconstrictor response to angiotensin 
II in hypertension.  
                 Other vasculotoxic responses in relation to angiotensin II are due to the 
activation of NADPH oxidase that may include low-density lipoprotein 
oxidation and increased mRNA expression for monocyte chemoattractant 
protein-1 and vascular cell adhesion molecule-1
[41]
.  It is clear that ACE 
inhibitors and ARBs block the activation of NADPH oxidase and hence limit 
oxidative reactions in the vasculature. These findings reveal that the ACE 
inhibitors and ARBs not only lower blood pressure but also has clinically 
[39] 
 
important vasoprotective effects. Important randomized clinical trials have 
also supported this hypothesis. 
                       
 
g) ENDOTHELIAL DYSFUNCTION: 
                   Nitric oxide is known to be a potent vasodilator, also inhibits platelet 
adhesion and aggregation, and suppresses migration and even proliferation 
of vascular smooth-muscle cells. Normal endothelial cells produce nitic 
oxide in response to various stimuli, which includes blood pressure changes, 
shear stress, and pulsatile stretch. It has an important role in the regulation of 
blood pressure, and thus indirectly both thrombosis and atherosclerosis
[42]
. 
[40] 
 
Healthy persons are continuously exposed to NO-dependent vasodilator 
tone, but this mechanism is diminished in hypertensive persons.  
                    Some observations reveal that in vivo superoxide dismutase (an 
intracellular enzyme reducing superoxide to hydrogen peroxide) delivery 
reduces blood pressure and even restores NO bioactivity. These evidences 
reveal that oxidant stress also contributes to the inactivation of NO in 
hypertensives and also lead to the development of endothelial 
dysfunction
[43]
. It is suggested that angiotensin II increases oxidant 
superoxide formation at minimal concentrations that bring minimal blood 
pressure changes
[44]
. Hence it is proposed that both increased oxidant stress 
and also endothelial dysfunction predisposes to hypertension.  
                 Though this concept is subject to debate, it is clear that antihypertensive 
drugs that inhibit the renin–angiotensin– aldosterone system, including ACE 
inhibitors, ARBs, and mineralocorticoid receptor antagonists, are effective in 
reversing endothelial dysfunction. This action at least partly accounts for 
their cardioprotective effect. 
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h) ENDOTHELIN: 
                  The antagonists to endothelin receptor reduce the blood pressure and 
also peripheral vascular resistance in both normotensives and mild to 
moderate hypertensives . This strongly interprets that endothelin plays a 
major role in the pathogenesis of hypertension
[45]
. 
                     The following illustrated figure shows both large conductance vessels 
(left), like epicardial coronary arteries, and resistance arterioles (right). It is 
well noted that in normal conductance arteries (top), there is free circulation 
of platelets and monocytes, and low-density lipoprotein oxidation is 
prevented by a preponderance of nitric oxide (NO) formation. There is a 
constant release of nitric oxide at the level of the small arterioles, hence 
reduced vascular tone is maintained.  Nitric oxide is known to be a potent 
vasodilator, also inhibits platelet adhesion and aggregation, and suppresses 
migration and even proliferation of vascular smooth-muscle cells. It is 
produced endogenously (within the body) from L- arginine ,  NADPH and 
O2 by nitric oxide synthase enzymes. 
 
[42] 
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                     Normally endothelin - 1 doesn‘t induce vasoconstriction or there will 
be only minimal vasoconstriction through type A endothelin receptors (ETA) 
stimulation found on smooth-muscle cells and also contributes to basal 
release of nitric oxide by stimulating type B endothelin receptors (ETB) 
located on endothelial cells. In the microvasculature (bottom) of 
hypertensives, decreased nitric oxide activity and increased ETA-mediated 
vasoconstrictor activity of endothelin-1 result in increased vascular tone and 
hypertrophy of tunica media, consequently resulting in increase in the 
systemic vascular resistance.  
                     A similar imbalance at the level of conductance arteries, leads to a 
proatherosclerotic picture like low-density lipoprotein oxidation, followed 
by the migration of monocytes, and then formation of foam cells. These 
activities culminates in the development of atherosclerotic plaques. If the 
plaque ruptures which is associated with enhanced platelet aggregation and 
impaired fibrinolysis, terminate in acute intravascular thrombosis, which 
explains why there is increased risk for cardiovascular problems in patients 
with hypertension
[46]
.  
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HYPERTENSION INDUCED TARGET ORGAN DAMAGE: 
HYPERTENSION AND HEART: 
1. LEFT VENTRICLE HYPERTROPHY(LVH): 
                              LVH can be identified by electrocardiography in only 5% to 
10% of patients with hypertension but by echocardiography it goes upto 
30% and it increases to 90% in patientss with severe hypertension
[47]
. More 
LVH is seen with abuse, diabetes, and hypercholesterolemia
[48]
. On the other 
hand, cardiac hypertrophy in response to excess load is nonpathologic in 
three circumstances such as maturation in infancy and childhood pregnancy, 
and high-level exercise.  
                           The chronic adaptation of the left ventricle to increased cardiac 
load is myocardial hypertrophy. Increased wall stress signals mRNA 
transcription to increase muscular proteins
[48]
. Pure BP overload leads to an 
increase in left ventricle wall thickness without concomitant increase in 
cavity volume, i.e., concentric hypertrophy. The LVH pattern can be 
modified by increased pulse-wave velocity, increased arterial stiffness and 
blood viscosity. 
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2. SYSTOLIC DYSFUNCTION:  
                              Hypertension can lead on to both systolic and diastolic 
dysfunction leading on to symptoms of congestive cardiac failure. Most of 
the time in cardiac failure, both co-exist together. It is characterized by a 
dilated heart and reduced ejection fraction in Echocardiogram. 
3. DIASTOLIC DYSFUNCTION: 
                          Diastolic dysfunction is more common in isolated hypertensive 
patients. Also around 1/3 of patients with congestive heart failure have 
diastolic dysfunction but their systolic function remains absolutely normal. 
Diastolic dysfunction is one of the earliest consequences of hypertension-
related heart disease and is aggravated by left ventricular hypertrophy and 
also ischemia. Cardiac catheterization provides the most accurate assessment 
of diastolic function of the heart. It can also be evaluated by 
echocardiography and radionuclide angiography which are noninvasive. 
                        Some of the important causes of diastolic dysfunction include 
hypertension, diabetes, aortic stenosis, constrictive pericarditis and 
restrictive cardiomyopathy. Diastole is the period of cardiac cycle during 
which both ventricles receive blood from their respective atrium by 
relaxation of ventricles. 
[46] 
 
                      Diastolic failure occurs when the ventricle can't be filled properly 
because its wall becomes thick or rigid so that it is difficult for it to relax 
normally. This situation occurs in a concentric hypertrophy. But in systolic 
heart failure there is usually an eccentric hypertrophy
[49]
. 
                      Diastolic failure is diagnosed by an elevated diastolic pressure in the 
left ventricle, but end diastolic volume will be normal. Histologically there is 
increased interstitial collagen deposition and infiltration of the myocardium. 
These leads to a decrease in distensibility and elasticity(ability to stretch) of 
the affected myocardium. As a result, cardiac output becomes diminished. 
When the left ventricular diastolic pressure is elevated, the pressure in 
atrium will also increase which is reflected in elevated pulmonary venous 
pressure which may lead on to pulmonary edema.  
                      The prognosis of diastolic dysfunction patients is better when 
compared to those with systolic dysfunction. Diastolic dysfunction is not 
synonymous with diastolic heart failure. Diastolic dysfunction can occur 
even in asymptomatic individuals and usually diagnosed during screening 
for some other cardiac problem. So diastolic dysfunction describes an 
abnormal mechanical property of ventricle whereas diastolic heart failure 
represents a clinical syndrome 
[47] 
 
      Characteristics of Patients with Systolic or Diastolic Heart Failure 
 
Characteristics Systolic Heart Failure Diastolic Heart Failure 
Age All ages, typically 50-70 
years 
Frequently elderly 
Sex More often male Frequently female 
Left ventricular ejection fraction Depressed, 
approximately 
40% or lower 
Preserved or normal, approximately 
40% or higher 
Left ventricular cavity size Usually dilated Usually normal, often with 
concentric left ventricular 
hypertrophy 
Left ventricular hypertrophy on 
electrocardiography 
Sometimes present Usually present 
Chest radiography Congestion and 
cardiomegaly 
Congestion with or without 
cardiomegaly 
Gallop rhythm present Third heart sound Fourth heart sound 
 
 
4. CORONARY ARTERY DISEASE: 
                  Hypertension is mostly the largest risk factor for coronary artery 
disease. The development of myocardial ischemia or infarction reflects an 
imbalance between myocardial oxygen supply and oxygen demand. 
Hypertension increases the risk by reducing the supply and increasing the 
demand. 
                Hypertensives suffer more silent ischemia and painless MI than do 
normotensives, perhaps because they have a lower sensitivity to pain
[51]
. And 
preexisting hypertension may not be recognized in patients who are seen 
immediately after an MI. Initially there may be an sudden increase in BP due 
[48] 
 
to the ischemia related pain, but the BP often falls immediately if pump 
function is impaired leading to cardiac failure
[50]
. 
                 Once an MI occurs, the prognosis or long term survival depends on 
blood pressure taken before and after the existing illness. In a study done by 
Kenchiah et al, the 28-day case fatality rate among 635 men who had an 
acute MI was 24.5% in those with a prior systolic BP  <140 mm Hg, 35.6% 
with a prior systolic BP of 140- 159 mm Hg, and 48.2% with a prior systolic 
BP of >=160 mm Hg.  
                On the other hand, an increase in post-MI mortality has been noted 
among those whose BP fell significantly, presumably a reflection of poor 
pump function. If the BP of these subjects remained elevated, the prognosis 
was even worse, likely representing a severe load on a damaged 
myocardium, so that care must be taken with patients who have either lower 
or higher BP after an infarction. 
5. ATRIAL FIBRILLATION: 
                          In a 16-year follow-up of 2,482 previously untreated 
hypertensives, 61 developed atrial fibrillation, a rate of 0.46 per 100 person 
years (Verdecchia et al., 2003b)
[52]
. The likelihood increased with increasing 
age, blood pressure levels, thickness of left ventricle, and diameter of the left 
[49] 
 
atrium. The risk of developing atrial fibrillation was reduced by over 60% in 
hypertensives treated down to a level below 120/80 (Young-Xu et al., 
2004)
[53]
. 
6. AORTIC STENOSIS: 
                Among 193 patients with symptomatic aortic stenosis, hypertension was 
present in 32%, and the additional workload was likely responsible for 
symptoms developing with larger valve areas and lower stroke work loss 
(Antonini-Canterin et al., 2003)
[54]
. The presence of aortic stenosis serves as 
an independent risk for cardiovascular disease in hypertensives (Olsen et al., 
2005)
[55]
. 
HYPERTENSION AND BLOOD VESSEL: 
            The vascular lesion caused by hypertension can be described as follows. 
 Fibrinoid necrosis as seen with acute rise of BP. 
 Hyperplastic or proliferative arteriolar sclerosis. 
 Hyaline arteriolar sclerosis, with thickening and hyalinization of the intima 
and media. 
 Miliary aneurysms in small cerebral penetration arterioles, usually at their 
first branching, which represent post stenotic dilations beyond areas of 
[50] 
 
intimal thickening and which, when they rupture, cause the cerebral 
hemorrhages so typical of hypertension. 
 Atherosclerotic plaques where thrombi form and which likely are 
responsible for the ischemia and infarction of heart, brain, kidney, and other 
organs that occur more frequently among hypertensives. 
 Medial damage in the wall of the aorta may lead to the formation of large 
plaques with eventual aneurysmal dilation and rupture, as well as aortic 
dissections. 
HYPERTENSION AND BRAIN: 
                  Stroke is the second most common cause of death in the world. It 
causes 5 million deaths per year. High blood pressure is the one of the 
strongest risk factor for stroke. Around 85% of strokes are due to infarction, 
and the remaining are due to either intracerebral or subarachnoid 
hemorrhage. The incidence of stroke rises progressively with increasing 
blood pressure levels, particularly systolic blood pressure in individuals >65 
years.  
                   Hypertension also is associated with impaired cognition in an aging 
population, and longitudinal studies support an association between midlife 
hypertension and late-life cognitive decline. Hypertension-related cognitive 
[51] 
 
impairment and dementia may be a consequence of a single infarct due to 
occlusion of a "strategic" larger vessel or multiple lacunar infarcts due to 
occlusive small vessel disease resulting in subcortical white matter ischemia. 
Several clinical trials suggest that antihypertensive therapy has a beneficial 
effect on cognitive function. 
                   Cerebral blood flow remains unchanged over a wide range of arterial 
pressures (mean arterial pressure of 50–150 mmHg) through a process 
termed autoregulation of blood flow. In patients with the clinical syndrome 
of malignant hypertension, encephalopathy is related to failure of 
autoregulation of cerebral blood flow at the upper pressure limit, resulting in 
vasodilation and hyperperfusion. Signs and symptoms of hypertensive 
encephalopathy may include severe headache, nausea and vomiting (often of 
a projectile nature), focal neurologic signs, and alterations in mental status.  
                      Untreated, hypertensive encephalopathy may progress to stupor, 
coma, seizures, and death within hours. Differential diagnoses for 
hypertensive encephalopathy includes cerebral ischemia, hemorrhagic or 
thrombotic stroke, seizure disorder, mass lesions, pseudotumor cerebri, 
delirium tremens, meningitis, acute intermittent porphyria, traumatic or 
chemical injury to the brain, and uremic encephalopathy. 
[52] 
 
HYPERTENSION AND KIDNEY: 
ALBUMIN 
                     The most abundant human protein available in blood is human 
albumin. Its main source of production is from the liver and constitutes more 
than one half of total blood protein
[56]
. T1/2= 20 days approximately. It is 
supposed to have a molecular mass of about 66.5kDa. The gene coding for 
albumin is found in chromosome 4. Any mutation in this gene may lead to 
formation of abnormal proteins. Preproalbumin is converted to proalbumin 
in the endoplasmic reticulum of liver, which is then cleaved to albumin in 
golgi apparatus and secreted out. 
 
                        Albumin helps in transportation of various hormones and other 
substances, buffers pH, maintain oncotic pressure. In healthy persons, 
albumin is not excreted through kidneys, because of their size and negative 
[53] 
 
electric charge. So the patient may have nil albumin, microalbuminuria or 
frank albuminuria in their urine sample.  
 
                      Microalbuminuria is the term used when urine albumin is 30-
300mg/l. The significance of microalbuminuria is that there is damage in the 
glomerulus leading to increased permeability of albumin and hence filtered 
out. It also indicates any evidence of subclinical cardiovascular abnormality, 
alterations in normal vascular endothelial function and also a prognostic 
marker in case of diabetes mellitus, systemic hypertension and post 
infectious glomerulonephritis. Progressive worsening of microalbuminuria 
[54] 
 
during first 24 hours of admission in a critical care unit may predict 
increased likelihood of morbidity and mortality. 
    
          Hypertensive Nephropathy: 
              Also termed as hypertensive nephrosclerosis or hypertensive renal disease 
refers to a condition causing damage to kidneys due to chronic hypertension.  
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           The pathogenesis of hypertensive nephropathy can be separated into 
3main categories, 
a) The levels of systolic and diastolic BP  
b) The degree of transmission of the pressure load to the renal vascular bed 
c) Localized susceptibility of tissues to any given degree of barotrauma 
                     Normal auto regulatory mechanisms prevent the episodic or sustained 
increase in blood pressure from reaching the renal microvasculature. Hence 
they provide a primary protection against hypertensive renal damage. As 
long as the BP remains within the autoregulatory range, only a benign 
nephrosclerosis is observed. If the blood pressure exceeds the threshold, 
acute disruptive injury (malignant nephrosclerosis) develops despite intact 
autoregulatory mechanisms. Once vascular injury develops autoregulatory 
mechanisms can be secondarily compromised and results in amplification of 
renal damage. Hence acute increase in BP (malignant hypertension) is more 
dangerous than chronic of the same range of blood pressure because of the 
time interval to get adapted by autoregulatory mechanisms. 
[56] 
 
 
                        However in the absence of severe hypertension, renal damage can 
still develop when the elevated systemic pressure is transmitted to the renal 
microvasculature. Such a situation primarily leads to accelerated 
glomerulosclerosis. In a vasoconstricted bed, the consequences of impaired 
autoregulation primarily results in decreased ability to maintain renal blood 
flow and GFR. When the systemic pressure is reduced in the patients, they 
may develop ischemic tubulointestitial disease. 
                    Benign nephrosclerosis: In benign nephrosclerosis, renal arterioles, 
particularly afferent arterioles, appear sclerosed due to hypertension, which 
further causes focal ischemia and ultimately leading to moderate decrease in 
glomerular filtration rate. Grossly, kidneys are shrunken with leathery 
appearance. The microscopic features reveal hyalinized arterioles with 
[57] 
 
thickened vessel wall, fibroelastic hyperplasia of the lobular/arcuate arteries, 
atrophy of the tubules, fibrosis of the interstitial and periglomerular regions 
which finally culminates to glomerulosclerosis. Vascular changes 
predominate in the afferent arteriole and particularly these vessels have 
characteristic absence of internal elastic lamina.  
                  Malignant nephrosclerosis: This refers to irreversible end organ damage 
of one or more organs. Grossly, the cortical surface of the kidney show 
pinpoint petechiae, which gives the characteristic flea bitten appearance. 
Microscopy reveals fibrinoid necrosis of the renal arterioles. The collagen is 
deposited in concentric layers appearing like onion skinning of arterioles 
(hyperplastic arteriolitis). There is also myointimal hyperplasia owing to 
persistently elevated blood pressure. The earliest change is the reduction in 
the size of the lumen due intimal thickening probably by myxoid connective 
tissue. Below are figures depicting the gross appearance of kidney in 
malignant nephrosclerosis with flea bitten appearance and microscopic 
appearance of fibrinoid necrosis of arterioles and histological appearance of 
onion skin lesion in hypertension. 
[58] 
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HYPERTENSION AND EYE: 
                  The patients with hypertensive retinopathy are expected suffer from 
hypertension which may be acute or chronic. However, the disease might be 
unknown to the patient and examination of the eye may yield us the first 
clue to his/her relatively asymptomatic disease. The age group most 
commonly involved may be middle age or elderly. Hypertension is 
interestingly more common in african-americans rather than the Caucasians. 
These patients are mostly free of symptoms or sometimes may present with 
nonspecific symptoms
[57]
. 
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                  The fundoscopic picture seen in hypertensive retinopathy includes 
cotton wool spot and most often with associated flame shaped hemorrhages. 
Rarely there may be any evidence of retinal or even macular edema. In end 
stage cases, there may be a macular star (appearance of ring of exudates 
extending from the disc upto the macula) and associated disc edema. 
Arteriolosclerosis leading to narrowing of arterioles, venous constriction and 
banking due to arterio-venous crossing, arteriolar color changes, sclerosis of 
vessels are often found concurrently
[57]
. 
               Hypertension may lay down cholesterol into tunica intima of arteries of 
medium and large size, which further reduces the lumen size of the vessels. 
In arteriolosclerosis, there may be focal closure of the retinal 
microvasculature, when this is associated with hypertension it may 
aggravate formation of micro infarcts and formation of superficial 
hemorrhages. There may be associated disc edema in extreme cases. The 
exact mechanism is unclear, increase in intracranial pressure which can be 
attributed to hypertension is proposed and hence it can be presumed to be a 
true papilledema
[57]
. 
               Even if the systemic blood pressure is brought under control, the 
arteriosclerotic changes occurred in the vasculature of retina persists. But the 
other retinopathy changes associated with hypertension may resolve in a 
[61] 
 
certain period of time with adequate control of BP. Within 24-48hours of 
increase in blood pressure, the patient may begin to develop cotton wool 
spots which may resolve in two to 10 weeks period with adequate control of 
blood pressure. Papilledema develop within few hours to days and takes 
weeks to months to revert back to normal. A macular star developing in a 
few week time, may take months to disappear after bringing the blood 
pressure under control
[57]
. 
 
               Managing hypertensive retinopathy is as simple as bringing the blood 
pressure under control as the first step. Whenever a patient presents with 
blurred vision due to papilledema as a result of hypertension, then the patient 
can be suspected to have malignant hypertension and should be suspected to 
be in crisis and intervened as early as possible. The patient immediately 
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needs a physician opinion, and has to be transported to a hospital with 
sophisticated emergency setup. 
                  It must be kept in mind, that there are many other conditions causing 
papilledema. Other probability like an intracranial mass must be kept in 
mind in such presentations. When a patient presents with extremely elevated 
blood pressure (e.g. 250/150mmhg) with associated  disc edema and a 
macular star, malignant hypertension is the most likely cause unless proves 
otherwise. 
Chronic hypertension producing retinal changes include the following, 
1. Arteriolosclerosis - narrowing of vessels which may be localized/generalized 
2. Arteriolar Copper wiring and silver wiring due to arteriolosclerosis  
3. Arteriovenous nicking due to arteriolosclerosis occurring in old age 
4. Any associated evidence of hemorrhage in the retina 
5. Loss of  nerve fiber layer  
6. Increased vascular tortuosity 
7. Remodeling changes due to capillary non perfusion, such as shunt vessels 
and micro aneurysms. 
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                        The first attempt to relate the retinal vascular changes to survival in 
the hypertensive patient was proposed by 3 personalities namely Keith, 
Wagner and Barker in the year 1939, who divided hypertensive patients into 
four groups on the basis of opthalmoscopic characteristics. This grouping 
correlated directly with the degree of systemic hypertension and inversely 
with the prognosis for survival. 
Grade 1 
          Mild generalized arteriolar constriction and associated vascular 
tortuosities. 
Grade 2 
                      Grade 1 + `arteriovenous nicking` or `arteriovenous nipping` 
Grade 3 
                      Grade 2 + associated cotton wool spots and also flame shaped    
hemorrhage 
 Grade 4 
                      Grade 3 + swelling of the disc i.e. papilledema   
[64] 
 
 
                   Hypertensive retinopathy can occur in 4 situations. In young patients 
where simple hypertension is not associated with any sclerosis , there will be 
generalized constriction of arterioles that may appear to be pale and unduly 
straight associated with acute angled branching, also flame shaped 
hemorrhages and cotton wool spots may occur. No evidence of hard 
exudates.  
                   Hypertension with involutionary sclerosis, as occuring in older 
patients, the picture of arteriosclerotic retinopathy occurs. There is localized 
constrictions and dilatations of the vessels with the thickening of the vessel 
[65] 
 
wall and deposition of hard exudates and sometimes hemorrhages without 
any edema. Gunn‘s sign- nipping and perpendicular placement of the veins 
is a diagnostic finding. Although vascular changes are bilateral, retinopathy 
remain confined to one eye due to carotid artery insufficiency on that side. 
                       In diffuse hyperplastic sclerosis, there will be proliferative and 
fibrotic changes mainly affecting the media. Vessels are narrow and tortuous 
with nicking at the arteriovenous crossing; multiple hemorrhages are 
present. In early stages, edema and cotton wool patches are seen while in 
later stages hard exudates are scattered diffusely, but usually forms a 
macular star. Though blindness doesn‘t occur in these patients, vision is 
severely impaired
[57]
. 
                       Hypertensive neuroretinopathy is the fundus change occuring in 
malignant hypertension. The entire disc is clouded by generalised edema 
which may be particularly attenuated at the disc, resulting in a marked 
degree of disc edema with multiple cotton wool patches, profuse hard 
exudates and prominent macular star. Vision is seriously impaired. With 
marked disc edema, prognosis is poor unless hypertension is under control. 
 
 
[66] 
 
                                            MATERIALS AND METHODS 
STUDY DESIGN: 
        Comparative study between two groups: 
 Prehypertension group:  
           It includes individuals belonging to the systolic BP of 120-139mmHg 
and a diastolic BP of 80-89mmHg. 
 Normotension group: 
          It includes individuals belonging to the systolic BP of <120mmHg and 
a diastolic BP of <80mmHg. 
SAMPLE: 
            Totally 100 subjects were selected and they were divided equally so 
that 50 members will be in each group. All were volunteers and all were 
mostly attenders of patients admitted to our wards in Tirunelveli Medical 
College Hospital. Volunteers from patient‘s attenders were selected because 
our study is to detect prehypertensive and normotensive individuals and to 
find out subclinical target organ damage in them. Patients will already be 
having some disease which itself would cause microalbuminuria and may 
bias our obtained results. 
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             The age group of individuals enrolled in this study are taken as 
above 30 years as per Non Communicable Diseases Screening Program.     
In all district hospitals non communicable diseases screening clinic is 
established and all patients above 30 years are screened for blood pressure 
and random blood sugar to detect diabetes and hypertension at early stages. 
The upper limit of age is kept within 60 years because at this age they 
develop any one of the risk factors like diabetes, hypertension and 
cardiovascular diseases. So getting a volunteer with purely prehypertension 
without any co morbidities becomes difficult at the age of above 60 years. 
INCLUSION CRITERIA:  
             Healthy volunteers, mostly patient‘s attenders above the age of 30 
years and below 60 years without any diseases or co morbidities mentioned 
in the exclusion criteria. Total sample size is 100, with 50 in each group. 
EXCLUSION CRITERIA: 
1. History of (H/O) Diabetes 
2. H/O Hypertension 
3. H/O Intake Of Drugs(aspirin, steroids, amoxicillin or antihypertensives) 
4. Pregnancy 
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5. History suggestive of urinary tract infection 
6. H/O Acute/ Chronic Kidney Disease 
7. H/O Coronary Artery Disease/Congestive Cardiac Failure 
8. H/O Acute Febrile Illness  
METHODOLOGY: 
            Informed consent of the volunteer was obtained first. A pro forma 
was prepared which includes the individual‘s name, age, sex, occupation and 
any specific complaints he was having at that time. These particulars were 
filled first. He was asked for any previous history of diabetes, hypertension, 
any drug intake, renal disease, cardiac disease or any acute illness. It was 
made sure that they do not have any of these diseases.  
             A routine systemic examination of the individuals was done 
including cardiovascular, respiratory, abdomen and nervous system. Their 
pulse rate and BP were measured. The BP was measured using standard BP 
cuff with the help of mercury sphygmomanometer. Before recording the 
patient it was made sure that the individual has avoided caffeine, exercise 
and smoking at least 30 minutes before measurement. The individual should 
be seated quietly and comfortably for at least 5 minutes in a chair. His/her 
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arm should be supported at the heart level and feet on the floor. Cuff should 
be applied over the artery at the level of heart and the lower edge of cuff 
should be at least 1 inch above the antecubital fossa. The blood pressure was 
measured in both the upper limb and also one of the lower limbs. Second 
measurement was done again with a gap of 30 minutes to confirm the 
previous readings. The average of upper limb BP recordings is noted. 
               Basic blood investigations like blood sugar, renal function tests and 
urine for albumin, sugar and deposits and electrocardiogram and chest X ray 
were performed routinely in all participants. 
ASSESSMENT OF END ORGAN DAMAGE: 
MICROALBUMINURIA:  
The various different methods available by which microalbuminuria 
can be estimated are: 
1. Microalbumin urine test strips: It uses immunochemical strips which are 
specific for albumin. 
2. Radio immunoassay: This technique is highly sensitive and has good 
accuracy but carries the disadvantage of radioactivity. 
3. Radio immune diffusion: This method requires long incubation period 
and hence is not widely accepted. 
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4. ELISA: Competitive and sandwich ELISA techniques are employed for 
quantification of albumin. 
5. Immunoturbidometry: Quantifies the amount of albumin based on 
spectrophotometric analysis and is suitable for analyzing large number of 
samples at a faster rate. 
TRADITIONAL METHOD FOR ALBUMINURIA: 
             In the laboratory, proteinuria/microalbuminuria has traditionally 
been detected with the use of multi-reagent urinary dipstick testing. 
 It is detected by a colorimetric reaction with the dipstick-impregnated 
reagent. 
 It has limited sensitivity for non-albumin protein and is therefore often 
falsely negative tubular proteinuria. 
 The sensitivity ranges from 83% to 98% with a specificity of 59% to 86%.  
 This reaction depends on the concentration of albumin, so the testing of 
larger volume diluted urine underestimates the degree of albuminuria.  
 Similarly, testing highly concentrated urine may overestimate the degree of 
albuminuria. 
 Markedly alkaline pH (>8.0) and administration of iodinated radio contrast 
agents can also produce false-positive results. 
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 The result obtained is reported as trace, 1+ up to 4+ which corresponds to 
urine albumin as designated in below table. 
 
    
OTHER METHODS FOR MICROALBUMINURIA: 
               A 24 hour urine sample can be obtained and albuminuria estimated 
is reported as follows: 
 <30mg/24 hours         – normal 
 30-300mg/24 hours    - micro albuminuria 
 >300 mg/24 hours      – macro albuminuria 
               The disadvantage of this method is need for a 24 hour collection 
which is little inconvenient for the patient and the test may give false 
positive or false negative result depending on the concentration of urine. For 
example if the urine volume is less, the concentration of albumin may 
increase so it may overestimate albuminuria. Similarly if a large volume of 
urine is obtained and it is dilute, it may underestimate albuminuria. 
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              Alternatively, nowadays a spot urine sample is preferred and spot 
urine albumin creatinine ratio (ACR) is performed. It is more reliable 
comparing to 24 hour urine sample. An early morning urine sample is 
preferred. The individual undergoing the test should refrain from doing any 
heavy exercise at least 24 hours before doing the procedure. The 
disadvantage of this procedure is that the creatinine values may be affected 
by the muscle mass of the individual. 
                  In our study we estimated the albumin creatinine ratio for 
assessing the presence of microalbuminuria. The reagent used were micro 
protein reagent for detection of albumin and sodium hydroxide/picric acid 
for the detection of creatinine. Both these reagents were filled in a fully 
automated analyser. The results are obtained using photometric techniques 
and fully automated turbidometry. 
The results are interpreted as:  
 <30mg/g                 - normal 
 30 – 300mg/g         - microalbuminuria 
 >300mg/g               - macroalbuminuria 
Since it is a ratio, the result obtained in mg/g are converted into ratio as <0.3 
as normal, 0.3 – 3 as microalbuminuria and  >3 as macroalbuminuria 
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FUNDUS CHANGES: 
           The retina of all the subjects were visualized with the help of direct 
ophthalmoscope and looked for any changes for hypertensive retinopathy 
was present or not. If present it was again confirmed with the help of 
ophthalmologist opinion. The grading were done according to Keith Wagner 
grading of hypertensive retinopathy 
DIASTOLIC DYSFUNCTION: 
          The diastolic period of the heart comprises of four phases mainly: 
 Isovolumetric relaxation period -  all the valves are closed 
 Early filling phase – ventricular filling due to pressure difference between 
atria and ventricle. Most of the blood enters during this phase 
 Diastasis – the pressure difference will become almost equal so very little 
flow during this period 
 Late filling phase or atrial contraction – due to atrial systole the remaining 
amount of blood enters into ventricle 
 
The diastolic dysfunction was assessed using following parameters: 
1. E wave velocity (velocity of flow during early filling phase),  
2. A wave velocity (velocity of flow during atrial contraction), 
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3.  E wave deceleration time (EDT)( time interval between the peak of E 
wave to zero) 
4.  Isovolumetric relaxation time (IVRT)  
 
 
Using these parameters the diastolic dysfunction is graded as follows: 
1. Grade I: (Abnormal relaxation pattern) 
2. Grade II (Pseudo normal pattern) 
3. Grade III (Reversible restriction) 
4. Grade IV (Irreversible restriction) 
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GRADE I:  
      Characterized by a decreased E wave velocity and increased A wave 
velocity. E/A ratio < 1; Increased IVRT (>100ms); Increased EDT (>240ms) 
GRADE II: 
          The normal left ventricle filling pattern is maintained as the E/A ratio 
>1. But left ventricle filling pressures are increased. It is identified by 
measuring a parameter atrial reversal (AR) velocity which is increased >35 
cm/s. 
GRADE III: 
        It is characterized by the following findings. E/A ratio>2.5; decreased 
EDT (< 150 ms); decreased IVRT (<70 ms); AR >35 cm/s. These findings 
are reversible with valsalva maneuver.  
GRADE IV:  
         Same as above but are irreversible with valsalva maneuver. 
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         Diagram to illustrate diastolic dysfunction in echocardiography 
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      OBSERVATION AND RESULTS 
 
SEX DISTRIBUTION: 
         Out of the 50 prehypertensive subjects, 36 of them are males and 14 
are females. Normotensives has almost equal sex distribution. 
                                                         TABLE.1 
                  
SEX Normotensives Prehypertensives 
MALE 26 36 
FEMALE 24 14 
TOTAL 50 50 
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AGE DISTRIBUTION: 
             Out of 50 prehypertensive individuals, around 48 belong to the age 
group of 30 to 50 years. Similar percentage is seen in normotensive group. 
                                                             
                                                              TABLE.2 
AGE Normotensives Prehypertensives 
30 TO 40 18 25 
41 TO 50 25 23 
51 TO 60 7 2 
TOTAL 50 50 
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DISTRIBUTION OF SMOKERS IN BOTH GROUPS: 
             Both the groups have almost equal number of smokers with 11 
smokers in normotensive group and 10 smokers in prehypertensive groups. 
                                                 TABLE.3 
SMOKING Normotensives Prehypertensives 
YES 11 10 
NO 39 40 
TOTAL 50 50 
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DISTRIBUTION OF ALCOHOL CONSUMERS IN BOTH GROUPS: 
              As of smokers, the number of persons who consume alcohol is 
equal in both groups with 12 individuals in both the groups. 
                                                    TABLE.4 
ALCOHOL Normotensives Prehypertensives 
YES 12 12 
NO 38 38 
TOTAL 50 50 
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BLOOD SUGAR DISTRIBUTION IN BOTH GROUPS: 
               All the individuals included in the study are made sure that they are 
not diabetic and so all of them have blood sugar values less than 110 mg% 
                                                            TABLE.5 
BLOOD 
SUGAR   
(mg/dl) 
Normotensives Prehypertensives 
70 TO 90 25 30 
91 TO 110 25 20 
TOTAL 50 50 
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BLOOD UREA DISTRIBUTION IN BOTH GROUPS: 
                 The individuals included in this study are made sure that they 
don‘t suffer from any kind of renal diseases. Hence all have blood urea value 
of less than 40mg%. 
                                                          TABLE.6 
BLOOD 
UREA             
(mg/dl) 
Normotensives Prehypertensives 
10 to 20 7 4 
21 to 40 43 46 
TOTAL 50 50 
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SERUM CREATININE DISTRIBUTION IN BOTH GROUPS: 
                 The individuals included in this study are made sure that they 
don‘t suffer from any kind of renal diseases. Hence all of them are having a 
serum creatinine value less than 1mg%. 
                                                              TABLE.7 
SERUM 
CREATININE  
(mg/dl) 
Normotensives Prehypertensives 
0.1 to 0.5 14 19 
0.6 to 1.0 36 31 
TOTAL 50 50 
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URINE ALBUMIN DISTRIBUTION IN BOTH GROUPS: 
                       In the prehypertensive individuals, 11 has mild excretion of 
albumin in urine of which 9 has trace albumin and 2 has trace albumin.  In 
normotensive groups none had albumin excretion in urine. 
                                                              TABLE.8 
URINE 
ALBUMIN 
Normotensives Prehypertensives 
TRACE 0 9 
1 + 0 2 
NIL 50 39 
TOTAL 50 50 
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URINE ALBUMIN/ CREATININE RATIO IN BOTH GROUPS: 
                     A cut off of 0.3 is taken, and those who have a ratio of more 
than 0.3 are said to have microalbuminuria. Those who have less than 0.3 
are designated as normal. In prehypertensive group, 14 members has ratio of 
more than 0.3. In normotensive group just 1 member is having a ratio of 
more than 0.3.  
                                                           TABLE. 9 
URINE 
ALBUMIN/CREATININE 
RATIO 
Normotensives Prehypertensives 
< 0.3 49 36 
 > 0.3  1 14 
 
  
                     To find out the significance of microalbuminuria in 
prehypertensive group, the urine albumin/ creatinine ratio of all the 100 
subjects are entered into a master chart. Data analysis was done using 
software called Epidemiological Information Package. 
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                     Using this software, all the range, frequencies, percentage, 
mean, standard deviation, chi square and p value can be calculated. The tests 
used are One way ANOVA test and Student‘s ‗t‘ test for data and Kruskul 
Wallis Chi-square test for consolidated tables. 
                    ‗p‘ value is calculated and value of less than 0.05 is considered 
significant. Here the ‗p‘value is <0.001 which is highly significant.  
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URINE ALBUMIN vs URINE ALBUMIN CREATININE RATIO: 
                  Here albuminuria tested by two different methods are correlated. 
It can be found that 15 subjects are having microalbuminuria in both the 
groups using albumin/creatinine ratio. Of these 11 subjects also tested 
positive for urine albumin through urine dip stick method. 
                                                  TABLE.10 
Urine albumin Normal Microalbuminuria 
  < 0.3  >  0.3 
Trace 0 9 
1+  0 2 
Nil 85 4 
TOTAL 85 15 
  
 
[88] 
 
FUNDUS FINDINGS IN BOTH GROUPS: 
            Out of 100 subjects, only 2 individuals had retinopathic changes 
related hypertension. Both had just generalized arteriolar constriction which 
falls under grade 1 hypertensive retinopathy according to Keith Wagner 
classification of hypertensive retinopathy. 
                                                          TABLE. 11 
FUNDUS -
RETINOPATHY 
GRADING 
Normotensives Prehypertensives 
GRADE 1 0 2 
NORMAL 50 48 
TOTAL 50 50 
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DIASTOLIC DYSFUNCTION IN BOTH GROUPS: 
                 Diastolic dysfunction can be identified using various parameters 
and it is usually graded from grade I to grade IV. Here we used E velocity 
which is velocity of blood flow during early diastole and A velocity which is 
velocity of blood flow during late diastole or atrial systole. Both the 
velocities are calculated and the ratio between them is made out.  Normally 
the ratio is > 1 but in grade I diastolic dysfunction there is a reversal of this 
ratio with <1. For calculating other grades, other parameters must be taken 
into account. Since in our study population all belonged to either normal or 
grade I diastolic dysfunction, other parameters are not taken into account for 
data collection, manipulation and for ‗p‘ values. 
                                                          TABLE.12 
E/A 
RATIO 
Normotensives Prehypertensives 
< 1.0 0 16 
1.0 to 1.25 16 10 
1.26 to 1.50 14 14 
1.51 to 1.75 12 6 
> 1.76 8 4 
TOTAL 50 50 
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                     To find out whether there is significant difference in presence 
of diastolic dysfunction between the two groups, the E velocity and V 
velocity values are entered into a master chart and E/A ratio is calculated 
which is also entered into the master chart. Data analysis was done using 
software called Epidemiological Information Package. 
 
                      Using this software, all the range, frequencies, percentage, 
mean, standard deviation, chi square and p value can be calculated. The tests 
used are One way ANOVA test and Student‘s ‗t‘ test for data and Kruskul 
Wallis Chi-square test for consolidated tables. 
                    ‗p‘ value is calculated and value of less than 0.05 is considered 
significant. Here the ‗p‘value is 0.004 which is less than 0.05 and hence it is 
highly significant. 
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AGE vs MICROALBUMINURIA: 
                  Out of the 15 individuals who are having microalbuminuria, only 
4 belong to the age group of 30 to 40years and 10 individuals belong to the 
age group of 40 to 50.  
                                                   TABLE.13 
AGE Normal      Microalbuminuria 
  < 0.3  >  0.3 
30 TO 40 39 4 
41 TO 50 38 10 
51 TO 60 8 1 
TOTAL 85 15 
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SEX vs MICROALBUMINURIA: 
               Out of the 15 individuals having microalbuminuria, 10 individuals 
are males and 5 are females.  
                                                    TABLE.14 
SEX Normal Microalbuminuria 
  < 0.3  >  0.3 
MALE 52 10 
FEMALE 33 5 
TOTAL 85 15 
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SMOKING vs MICROALBUMINNURIA: 
             Out of the 15 individuals who are having microalbuminuria, it can 
be noted that 4 are smokers and 11 are non smokers. 
                                                    TABLE.15 
Smoking Normal Microalbuminuria 
  < 0.3  >  0.3 
YES 17 4 
NO 68 11 
TOTAL 85 15 
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ALCOHOL vs MICROALBUMINURIA:  
                    Out of the 15 individuals who are having microalbuminuria, 4 
individuals are the one who consumes alcohol and 11 individuals doesn‘t 
consume alcohol. 
                                                  TABLE.16 
Alcohol Normal Microalbuminuria 
  < 0.3  >  0.3 
YES 19 5 
NO 66 11 
TOTAL 85 15 
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AGE vs FUNDUS/DIASTOLIC DYSFUNCTION: 
               Both the prehypertensive individuals with grade I hypertensive 
retinopathy falls in the age group of 41 to 50. Out of 16 individuals with 
diastolic dysfunction, 10 fall in the age group of 41 to 50. 
                                                                              TABLE.17 
  FUNDUS EXAMINATION 
GRADE OF DIASTOLIC 
DYSFUNCTION TOTAL 
AGE Grade 1 Normal Grade 1 Normal   
30 TO 40 0 43 4 39 43 
41 TO 50 2 46 9 39 48 
51 TO 60 0 9 2 7 9 
TOTAL 2 98 15 85 100 
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SEX vs FUNDUS/DIASTOLIC DYSFUNCTION: 
                    Out of the 16 subjects with diastolic dysfunction, 12 are males 
and those with fundus changes fall one in each sex. 
                                                                              TABLE. 18 
  FUNDUS EXAMINATION 
GRADE OF DIASTOLIC 
DYSFUNCTION   
SEX Grade 1 Normal Grade 1 Normal TOTAL 
MALE 1 61 12 50 62 
FEMALE 1 37 4 34 38 
TOTAL 2 98 16 84 100 
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SMOKING vs FUNDUS/DIASTOLIC DYSFUNCTION: 
               In the individuals with diastolic dysfunction out of 16, 11 are non 
smokers and 5 are smokers. In those with retinopathy, one is a smoker and 
other is a non smoker. 
                                                                               TABLE.19 
  FUNDUS EXAMINATION 
GRADE OF DIASTOLIC 
DYSFUNCTION   
SMOKING Grade 1 Normal Grade 1 Normal TOTAL 
YES 1 20 5 16 21 
NO 1 78 11 68 79 
TOTAL 2 98 16 84 100 
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ALCOHOL vs FUNDUS/DIASTOLIC DYSFUNCTION:  
                     The distribution among alcohol consumers is exactly similar to 
that of smokers. 5 alcohol consumers in individuals with diastolic 
dysfunction and 1 in subjects with retinopathy. 
                                                                                  TABLE.20 
  FUNDUS EXAMINATION 
GRADE OF DIASTOLIC 
DYSFUNCTION   
ALCOHOL Grade 1 Normal Grade 1 Normal TOTAL 
YES 1 23 5 19 24 
NO 1 75 11 65 76 
TOTAL 2 98 16 84 100 
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MICROALBUMINURIA vs DIASTOLIC DYSFUNCTION: 
               Out of the 15 subjects who are having microalbuminuria, 9 subjects 
are having associated diastolic dysfunction. 
                                                TABLE.21 
  Diastolic dysfunction 
ACR Normal Grade 1 
> 0.3 6 9 
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MICROALBUMINURIA vs FUNDUS CHANGES: 
            Out of 15 subjects with microalbuminuria, only one has associated 
fundus changes in the form of grade I hypertensive retinopathy. 
                                                           TABLE.22 
  Fundus 
ACR Normal Grade 1 
> 0.3 14 1 
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DISCUSSION 
 
SEX DISTRIBUTION: 
               It can be noted from Table.1 that distribution of males and females 
is almost equal in the normotensive group whereas in the prehypertensive 
group, around 68% are males and the remaining 32% constitutes females. 
According to the survey did by NHANES in the United States, the 
prevalence of prehypertensives in that population was 39 percent among 
men and 23 percent among females
[2]
. 
AGE DISTRIBUTION: 
               As per our study (Table.2), around 96% of individuals in 
prehypertensive group belonged to the age group of 30 to 50 years. After the 
age of 50 years the incidence of hypertension itself increases. And the end 
organ damage caused by increased blood pressure also increases along with 
the age. So detecting prehypertensive individuals at early age becomes 
important. According to Framingham Heart Study, those in the age group of 
65 years and above progresses from prehypertension to hypertension at a 
rate of 42% when compared to lower age group whose progression rate was 
27%
[61]
. 
[104] 
 
SMOKING AND ALCOHOL CONSUMPTION DISTRIBUTION: 
               As per our study, around 47% of smokers had prehypertension and 
50% of non smokers had prehypertension, (Table 3 and Table 4). In case of 
alcohol consumption the distribution is exactly 50%. 
             Alcohol consumption, smoking and hypertension are always 
associated with each other in causing a cardiovascular event. They act 
synergistically together. Whether smoking has a long term effect on 
elevation of BP is a question to rise. After a puff of cigarette smoking there 
is an acute rise of BP due to increased sympathetic activation. But long term 
effect of smoking on BP has been studied. 
              In a health survey done in England
[70]
, it has been found that the 
light smokers has a significantly lower BP when compared to heavy 
smokers. But these individuals do not consume alcohol. When alcohol 
considered along with alcohol BP is more in those with both the habits than 
with smoking alone.  
            In another epidemiological survey
[71]
, the blood pressure was found 
to slightly lower in the smokers when compared to non smokers. This has 
been attributed to the vasodilatory effect of nicotine present in the cigarette. 
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BLOOD SUGAR, BLOOD UREA and SERUM CREATININE: 
            One of the important causes of microalbuminuria apart from 
hypertension is diabetes and renal disease. Diabetes and renal failure patients 
can be a confounding factor in our study if included in our study. Hence in 
our study it is made sure that all of them had a blood sugar values and the 
blood urea and serum creatinine values within normal range (Table 5,   
Table 6 and Table 7). 
URINE ALBUMIN and URINE ALBUMIN CREATININE RATIO: 
             In our study, the presence of albumin in urine was tested by both 
routine dipstick method and by deriving albumin creatinine ratio. According 
to dipstick method, around 22% of prehypertensive individuals had albumin 
in urine in which 4% had a 1+ albumin which corresponds to 30 – 100mg/dl 
of albumin and remaining 18% had a trace albumin which corresponds to 
30-100mg/dl.  
            In the other method of measurement of albumin creatinine ratio, 2% 
of normotensive individuals had microalbuminuria and 28% of 
prehypertensive individuals had microalbuminuia. ‗p‘ was calculated which 
was < 0.001 which was highly significant.  
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           In a study done in Korea, the presence of microalbuminuria was 
studied in prehypertensive individuals. The prehypertensive individuals are 
divided into two groups as BP in the range of 130-139/85-89mmHG and BP 
of 120-129/80-84mmHg. The study showed that presence of 
microalbuminuria is significantly higher in the high BP group individuals
[66]
.                            
            In another similar study the presence of microalbuminuria was found 
to be higher in prehypertensive group than in normotensive group. In the 
same study the levels of serum uric acid was found to be higher in 
prehypertensive people than the normotensive people
[65]
.  
RETINOPATHY IN PREHYPERTENSION: 
            In our study, only 4% of them had changes of grade I hypertensive 
retinopathy(Table.11). That too they belonged to the prehypertensive group. 
Though this is statistically insignificant still the presence of arteriolar 
changes in those individuals needs to be addressed.  
           In a study done in a Medical University in Italy
[72]
, they noticed 
incipient signs of hypertensive retinopathy in patients who had a normal BP. 
They did an ambulatory BP measurement in those individuals and they 
found that they fall in the prehypertensive BP range. It was termed as 
Minimal Lesion Hypertensive Retinopathy. 
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DIASTOLIC DYSFUNCTION IN PREHYPERTENSION: 
             In our study population, around 32% of them had a grade I diastolic 
dysfunction according to their recorded E velocity, A velocity and its ratio   
(Table.12). All belonged to the prehypertensive group. The ‗p‘ value is 
calculated by chi square test and it was 0.004 which was highly significant. 
            In a study published in pubmed, the diastolic dysfunction was 
assessed in prehypertensive individuals. The diastolic dysfunction was 
assessed using various parameters. The result was diastolic dysfunction was 
higher in prehypertensives than normotensives
[67]
.  
AGE AND END ORGAN DAMAGE:  
            In prehypertensive group those with microalbuminuria, 9% fall in the 
age group of 30-40 years, 20% in the age group of 40-50 years and 11% in 
the age group of 50-60 years (Table13).  As age advances, the risk of end 
organ damage increases. In the same group, the distribution of diastolic 
dysfunction is in the form of 9% in age group of 30-40 years, 18% in age 
group 40-50 years and 22% in age group 50-60 years(Table 17). 
              The diastolic dysfunction increases as age progresses as the effect 
of sustained high BP on end organ occurs faster in older age group 
population. 
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SEX AND END ORGAN DAMAGE: 
             In the prehypertensive group those with microalbuminura, 16% are 
males and 13% are females (Table 14). In the same group those with 
diastolic dysfunction, 19% are males and females are 10% (Table 18). So 
males have more end organ damage than females. The rate of progression of 
BP is usually higher in males than females up to age of 60 years after which 
it raises for females. The males have associated risk factors like smoking and 
alcohol consumption which would have contributed to their higher 
percentage of end organ damage. 
SMOKING AND END ORGAN DAMAGE:  
            In the prehypertensive group those with microalbuminura, 19% are 
smokers and 13% are non smokers(Table 15). In those with fundus changes 
1 is a smoker and the other is a non smoker(Table19). In those with diastolic 
dysfunction, 25% are smokers and 13% are non smokers(Table 19).  
            So smokers have higher percentage of end organ damage when 
compared to non smokers.  
            Stephan R. Orth et al, studied the relationship of smoking and 
kidney. The result obtained was that when smoking present in a hypertensive 
individual, the risk microalbuminuria is doubled and smoking itself is a risk 
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factor for microalbuminuria even in a non diabetic and non hypertensive 
individuals
[73]
.  
             Stork et al studied the correlation of smoking and diastolic function. 
The smokers with coronary artery disease had associated diastolic 
dysfunction. This is because the nicotine in smoke had caused a shift of 
mitral blood flow from E wave to A wave thus reversing the normal E/A 
ratio. 
ALCOHOL AND END ORGAN DAMAGE:  
            In our study population, the prehypertensive individuals with 
microalbuminuria had 20% alcohol consumers and 14% of them don‘t 
consume alcohol (Table 16). In those with fundus changes 1 consumes and 
the other doesn‘t consume (Table 20). In those with diastolic dysfunction 
similar to microalbuminuria, 20% of them consume alcohol and 14% of 
them don‘t consume alcohol (Table 20).  
           Alcohol usually worsens the existing microalbuminuria. The toxins 
and wastes produced by alcohol consumption are not properly filtered by the 
existing end organ damage which may further cause renal injury. Also 
alcohol favours dehydration, in a state where protein excretion is increased 
in urine.  
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MICROALBUMINURIA AND DIASTOLIC DYSFUNCTION: 
            Around 60% of those with microalbuminuria had an associated grade 
I diastolic dysfunction which is significant (Table 21). In several studies it 
has shown that microalbuminuria is a risk factor for a future vascular event 
either in the form of coronary heart disease or a stroke either in the 
background of hypertension, diabetes or a renal disease. And the prognosis 
is comparatively poor for those individuals.  
MICROALBUMINURIA AND RETINOPATHY: 
              Only 6% percent of those with microalbuminuria had retinopathy 
changes. The retinopathy usually occurs after long standing hypertension. 
Since our study is on prehypertension we had only two subjects with 
retinopathy. But still there is a good association between microalbuminuria 
and retinopathy in presence of high blood pressure in which several studies 
has been done.  
                The relationship between retinopathy and microalbuminuria was 
studied by Biesenbach in a group of patients with essential hypertension. He 
found that retinopathy is more in patients with persistant microalbuminuria 
than in patients whose microalbuminuria has been adequately treated
[75]
.                                                                          
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CONCLUSION 
             As per our study,  
 Prehypertension is more common in males than females 
 Most of the individuals with prehypertension belonged to the age 
group of 30 to 50 years than above 50 years 
 Out of prehypertensive individuals, the distribution of smokers and 
alcohol consumers was almost 50%. So significant correlation 
between smoking and alcohol consumption with prehypertension 
could not be made out 
 None of the individuals included in the study had diabetes or renal 
disease as evidenced by normal blood sugar values and normal renal 
function tests 
 Presence of microalbuminuria is more common in prehypertensive 
individuals than normotensive individuals. It is statistically significant 
 Retinopathy is more common in prehypertensive individuals than 
normotensive individuals though it is statistically insignificant. 
[112] 
 
 Diastolic dysfunction is more common in the prehypertensive group 
than normotensive individuals evidenced by statistically significant 
‗p‘ value. 
 The percentage of presence of end organ damage increased as the age 
progressed. 
 Males had a more percentage of end organ damage when compared to 
females. 
 The presence of end organ damage is more common in smokers and 
alcohol consumers. 
 Most of the individuals with microalbuminuria had associated 
diastolic dysfunction.  
              So according to our study even at the prehypertensive stage people 
starts to develop end organ damage. So whether they have to be treated with 
antihypertensive drugs need to be addressed. According to TROPHY (Trial 
Of Preventing Hypertension)
[76]
 trial which included 800 prehypertensive 
subjects were treated with candesartan 16mg for 2 years and placebo. At the 
end of study there was a significant reduction in incident hypertension in 
subjects who received candesartan compared with those who receive 
placebo. 
[113] 
 
               But JNC 7 advises life style modification for prehypertensive 
individuals
[4]
. However JNC 8
[77]
 doesn‘t address the prehypertensive stage. 
So detailed studies needed regarding drug therapy for prevention of 
progression of prehypertension to overt hypertension and for 
prehypertensive individuals with end organ damage.  
               At the outset of our study, we suggest that all the patients need to 
be screened for the presence of high blood pressure above the age of 30 
years whatever may be their presenting symptom. If detected to be in a 
prehypertensive stage of blood pressure, advise at least a urine albumin test 
to look for any microalbuminuria. They needed to be followed up with 
regular monitoring of BP either every 6 months, 1 year or whatever way it is 
feasible.  
                Above all life style modifications should be strongly encouraged 
for those individuals. It includes: 
 DIET - They should be advised DASH (Dietary Approaches To Stop 
Hypertension) diet. It is rich in fruits and vegetables and low fat or 
non fat diary. It is rich in potassium and calcium and contains limited 
amounts of meats and sweets
[78] 
.DASH diet reduces systolic BP by 
5.5mmHg and diastolic BP by 3.0mmHg. 
[114] 
 
 Increased body weight is a risk factor for prehypertension and hence a 
weight reduction should be strongly recommended for them. Studies 
found that for 1 kg reduction of weight systolic BP decreases by 
1.05mmHg and diastolic BP decreases by 0.92mmHg. It also 
improves the abnormal left ventricular relaxation
[79]
.  
 Limitation of salt intake. It has a definite role in preventing 
hypertension but it is difficult to maintain in general public and so a 
strong motivation needed.  
 Regular physical activity. They should exercise > 3 times a week at 
least 30 minutes they should exercise. 
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ANNEXURE – 1 
PROFORMA 
S. No: 
NAME:                                         AGE/SEX: 
OCCUPATION:                                                   
COMPLAINTS IF ANY: 
 
GENERAL EXAMINATION: 
   Pulse rate:                              BP: 
 
SYSTEMIC EXAMINATION: 
1. CVS: 
2. RS: 
3. P/A: 
4. CNS: 
[128] 
 
 
PAST HISTORY: 
   1. H/O DIABETES: YES/NO 
   2. H/O HYPERTENSION: YES/NO 
   3. H/O KIDNEY DISEASE: YES/NO 
   4. H/O CAHD/CCF: YES/NO 
   5. H/O ACUTE FEBRILE ILLNESS: YES/NO 
   6. H/O DRUG INTAKE: YES/NO 
   7. H/O TUBERCULOSIS: YES/NO 
   8. H/O PREGNANCY: YES/NO 
PERSONAL HISTORY:  
1. H/O SMOKING: YES/NO 
2. H/O ALCOHOL INTAKE: YES/NO 
3. H/O DRUG ABUSE: YES/NO 
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INVESTIGATIONS  
 BLOOD SUGAR: 
 
 BLOOD UREA: 
 
 SERUM CREATININE: 
 
 URINE ROUTINE: 
 
 ELECTROCARDIOGRAM: 
 
 CHEST X RAY: 
 
 SPOT URINE ALBUMIN CREATININE RATIO: 
 
 ECHOCARDIOGRAM: 
 
 FUNDUS: 
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ANNEXURE – 2 
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1 KRISHNA 31     M YES NO 110/70 90 23 0.7 NIL 0.08 NORMAL 1.14 0.54 2.11 NORMAL
2 ASHRAF 39     M NO NO 134/88 90 31 0.4 TRACE 0.42 NORMAL 1.07 0.53 2.01887 NORMAL
3 PANDI 54     M YES YES 130/86 84 36 0.9 TRACE 0.431 NORMAL 0.64 1.1 0.58182 GRADE 1
4 RAM 46     M YES YES 100/68 96 31 0.7 NIL 0.184 NORMAL 0.61 0.54 1.12963 NORMAL
5 ARIVU 49     M NO NO 118/74 90 30 0.6 NIL 0.194 NORMAL 0.864 0.54 1.6 NORMAL
6 ARAVAN 42     M NO YES 108/70 88 30 0.5 NIL 0.24 NORMAL 0.613 0.41 1.49512 NORMAL
7 KUMARI 51     F NO NO 118/70 78 18 0.6 NIL 0.08 NORMAL 0.763 0.546 1.3974 NORMAL
8 RAJATHI 36     F NO NO 112/74 91 31 0.8 NIL 0.112 NORMAL 0.861 0.542 1.5885 NORMAL
9 KASI 50     M NO YES 116/72 96 34 0.4 NIL 0.342 NORMAL 0.962 0.512 1.878 NORMAL
10 VAIRAM 49     M YES YES 130/86 90 31 0.7 NIL 0.24 GRADE 1 1.081 0.725 1.491 NORMAL
11 RATHNABAI 58     F NO NO 110/70 86 14 0.8 NIL 0.15 NORMAL 1.17 0.62 1.887 NORMAL
12 SHEELA 46     F NO NO 112/76 96 21 0.6 NIL 0.16 NORMAL 0.89 0.56 1.589 NORMAL
13 PUSHPAM 36     F NO NO 116/76 90 24 0.7 NIL 0.2 NORMAL 0.84 0.424 1.98 NORMAL
14 LEELAVATHI 38     F NO NO 132/88 82 29 0.6 NIL 0.24 NORMAL 0.864 0.563 1.534 NORMAL
15 THANUSHA 39     F NO NO 128/86 88 24 0.7 NIL 0.181 NORMAL 0.681 0.452 1.506 NORMAL
16 SRINIVASAN 48     M NO YES 110/70 78 28 0.7 NIL 0.25 NORMAL 0.751 0.563 1.33 NORMAL
17 SRIDHAR 33     M NO NO 130/88 90 30 0.9 NIL 0.49 NORMAL 0.751 0.44 1.783 NORMAL
18 RAJESWARI 46     F NO NO 112/60 91 30 0.7 NIL 0.1 NORMAL 0.8621 0.53 1.626 NORMAL
19 THANGAM 55     F NO NO 110/60 99 33 0.6 NIL 0.26 NORMAL 0.864 0.527 1.639 NORMAL
20 GANESH 38     M NO NO 132/84 96 30 1 NIL 0.17 NORMAL 0.912 0.67 1.361 NORMAL
21 RAJU 43     M YES YES 130/88 96 28 0.7 TRACE 0.51 NORMAL 1.05 0.82 1.28 NORMAL
22 THANGARAJ 56     M NO YES 108/70 76 28 0.9 NIL 0.25 NORMAL 0.93 0.85 1.09 NORMAL
23 LEELA 44     F NO NO 138/88 94 27 0.7 NIL 0.43 NORMAL 0.85 0.71 1.197 NORMAL
24 HEPCIBA 37     F NO NO 112/78 98 20 0.4 NIL 0.15 NORMAL 0.735 0.61 1.204 NORMAL
25 GEETHA 33     F NO NO 116/78 101 23 0.6 NIL 0.23 NORMAL 0.86 0.621 1.384 NORMAL
26 ANTHONYRAJ 32     M NO NO 130/84 86 18 0.5 NIL 0.26 NORMAL 1.07 0.93 1.15054 NORMAL
27 ALAGAPPAN 37     M NO NO 128/88 91 17 0.6 NIL 0.141 NORMAL 0.954 0.84 1.13571 NORMAL
28 KUMAR 42     M NO NO 110/60 97 21 0.7 NIL 0.261 NORMAL 0.76 0.62 1.22581 NORMAL
29 SITALAKSHMI 42     M NO NO 130/86 95 28 0.4 NIL 0.251 NORMAL 0.94 1.02 0.92157 GRADE 1
30 RAJESH 46     M NO NO 114/72 101 27 0.6 NIL 0.172 NORMAL 0.9 0.73 1.23288 NORMAL
31 DEEPAK 40     M NO NO 132/88 90 30 0.4 NIL 0.223 NORMAL 0.968 0.62 1.561 NORMAL
32 NARASIMAN 49     M NO NO 112/60 104 31 0.4 NIL 0.21 NORMAL 0.762 0.65 1.17 NORMAL
33 SATHASIVAM 54     M YES YES 114/70 99 29 0.9 NIL 0.2 NORMAL 1.14 0.84 1.357 NORMAL
34 ALAGURAJ 46     M YES YES 128/84 101 20 0.6 TRACE 0.52 NORMAL 0.712 0.89 0.8 GRADE 1
35 RAJENDRAN 50     M YES YES 136/80 104 30 0.9 1 + 0.6 NORMAL 0.84 0.91 0.92 GRADE 1
36 ARASAN 42     M YES YES 116/76 100 31 0.8 NIL 0.15 NORMAL 0.72 0.63 1.14 NORMAL
37 RADHA 37     F NO NO 106/70 96 31 0.6 NIL 0.22 NORMAL 0.84 0.73 1.13 NORMAL
38 RAMESH 40     M YES YES 126/84 94 29 0.9 NIL 0.16 NORMAL 0.75 0.61 1.22 NORMAL
39 THANGAMMAL 48     F NO NO 108/70 99 17 0.7 NIL 0.27 NORMAL 0.85 0.64 1.32 NORMAL
40 NIRMALA 44     F NO NO 112/70 96 31 0.7 NIL 0.22 NORMAL 0.64 0.52 1.23 NORMAL
41 ALAGESAN 44     M NO YES 126/86 106 33 0.9 NIL 0.24 NORMAL 0.82 0.76 1.08 NORMAL
42 POORNIMA 40     F NO NO 118/74 96 36 0.7 NIL 0.2 NORMAL 0.82 0.71 1.16 NORMAL
43 ABI 40     M NO NO 130/80 92 28 0.6 NIL 0.24 NORMAL 0.72 0.53 1.35 NORMAL
44 ABINAYA 41     F NO NO 130/88 90 40 0.6 NIL 0.16 NORMAL 1.02 0.62 1.64 NORMAL
45 SEETHA 40     F NO NO 110/70 86 26 0.6 NIL 0.14 NORMAL 0.53 0.95 1.79 NORMAL
46 NESAN 40     M YES NO 112/76 88 31 0.4 NIL 0.16 NORMAL 1.14 0.83 1.37 NORMAL
47 PETER 48     M NO NO 130/80 96 26 0.5 TRACE 0.54 NORMAL 0.63 0.78 0.8 GRADE 1
48 ANBU 48     M YES YES 134/86 94 30 0.4 NIL 0.22 NORMAL 0.86 0..64 1.34 NORMAL
49 REKHA 49     F NO NO 100/70 84 17 0.4 NIL 0.15 NORMAL 0.67 0.43 1.55 NORMAL
50 NAGESH 46     M NO YES 134/86 78 21 0.7 NIL 0.15 NORMAL 0.76 0.49 1.55 NORMAL
51 RATHNAM 52     F NO NO 110/70 88 21 0.6 NIL 0.14 NORMAL 1.08 0.73 1.48 NORMAL
52 SAKTHI 48     F NO NO 112/70 82 23 0.6 NIL 0.25 NORMAL 1.24 0.86 1.43 NORMAL
53 KRISHNAMOORTHI 42     M NO NO 110/70 97 25 0.9 NIL 0.16 NORMAL 0.96 0.67 1.44 NORMAL
54 REENA 41     F NO NO 130/88 90 27 0.4 NIL 0.28 NORMAL 0.85 0.93 0.91 GRADE 1`
55 MAKHIL 39     F NO NO 128/82 86 24 0.6 NIL 0.17 NORMAL 0.78 0.64 1.21 NORMAL
56 ARASI 40     F NO NO 110/60 93 31 0.3 NIL 0.2 NORMAL 0.67 0.45 1.48 NORMAL
57 SHANKAR SIVAM 37     M NO NO 126/84 86 24 0.7 NIL 0.09 NORMAL 1.13 0.64 1.76 NORMAL
58 SANTHOSH 41     M NO NO 126/80 86 21 0.7 NIL 0.16 NORMAL 1.2 0.78 1.53 NORMAL
59 PREM 39     M NO NO 130/88 90 27 0.4 NIL 0.16 NORMAL 0.67 0.56 1.19 NORMAL
60 ABDUL 41     M NO NO 102/70 90 29 0.2 NIL 0.16 NORMAL 0.64 0.58 1.1 NORMAL
61 GLADY 41     F NO NO 112/70 87 26 0.2 NIL 0.12 NORMAL 1.07 0.68 1.57 NORMAL
62 VEERA 39     M NO NO 128/86 90 28 0.6 NIL 0.26 NORMAL 0.86 0.74 1.15 NORMAL
63 GUHAN 33     M NO NO 134/86 81 33 0.6 NIL 0.06 NORMAL 0.87 0.92 0.94 GRADE 1
64 HARI 37     M NO NO 122/82 90 24 0.3 NIL 0.14 NORMAL 0.82 0.63 1.29 NORMAL
65 BALAN 37     M NO NO 130/80 83 27 0.3 NIL 0.12 NORMAL 0.68 0.81 0.83 GRADE 1
66 ALEX 39     M NO NO 126/86 79 29 0.4 NIL 0.1 NORMAL 1.09 0.83 1.31 NORMAL
67 ANBU 33     M NO NO 110/70 94 26 0.4 NIL 0.07 NORMAL 0.76 0.61 1.24 NORMAL
68 PRABHU 37     M NO NO 126/84 96 19 0.2 NIL 0.17 NORMAL 0.68 0.48 1.41 NORMAL
69 RAMAN 42     M YES YES 132/82 97 21 0.9 NIL 0.24 NORMAL 1.15 1.24 0.92 GRADE 1
70 RAJAN MOORTHY 40     M YES YES 106/70 91 24 0.3 NIL 0.11 NORMAL 1.24 0.64 1.93 NORMAL
71 MURUGAN 47     M YES YES 110/70 90 29 0.7 NIL 0.12 NORMAL 0.92 0.45 2.06 NORMAL
72 MOHAN 50     M NO NO 132/84 78 24 0.3 TRACE 0.52 NORMAL 1.08 1.13 0.95 GRADE 1
73 MOOKIAH 48     M NO NO 118/78 81 17 0.6 NIL 0.12 NORMAL 0.85 0.49 1.73 NORMAL
74 KOMBIAH 42     M NO YES 118/78 86 24 0.9 NIL 0.23 NORMAL 0.69 0.45 1.53 NORMAL
75 RAJIAH 45     M NO NO 130/86 86 26 0.6 TRACE 0.79 NORMAL 1.08 1.32 0.81 GRADE 1
76 ATHINARAYANAN 31     M NO NO 132/88 90 31 0.4 NIL 0.22 NORMAL 0.79 0.56 1.41 NORMAL
77 GUPTA 37     M NO NO 110/70 86 34 0.7 NIL 0.15 NORMAL 0.86 0.69 1.24 NORMAL
78 NANDHINI 36     F NO NO 138/84 96 24 0.6 TRACE 0.46 NORMAL 0.99 1.17 0.84 GRADE 1
79 NALINI 39     F NO NO 132/84 94 27 0.3 NIL 0.41 NORMAL 0.96 1.24 0.77 GRADE 1
80 THANGALEELA 43     F NO NO 110/60 86 34 0.6 NIL 0.09 NORMAL 1.42 1.05 1.35 NORMAL
81 THANGAPUSHPAM 43     F NO NO 134/88 90 30 0.5 1 + 0.72 NORMAL 0.78 0.94 0.82 GRADE 1
82 SITA 40     F NO NO 130/86 88 24 0.6 NIL 0.26 NORMAL 1.13 0.76 1.48 NORMAL
83 MARY 39     F NO NO 108/60 92 26 0.6 NIL 0.06 NORMAL 0.76 0.68 1.11 NORMAL
84 PUSPAM 40     F NO NO 130/84 90 25 0.7 NIL 0.16 NORMAL 0.82 0.69 1.18 NORMAL
85 BALA 47     M NO YES 112/72 94 29 0.7 NIL 0.14 NORMAL 0.87 0.74 1.17 NORMAL
86 VELAYUDHAM 51     M YES NO 110/70 90 31 0.6 NIL 0.28 NORMAL 1.25 0.76 1.64 NORMAL
87 DUKE 40     M NO NO 128/80 78 36 0.4 NIL 0.22 NORMAL 0.67 0.53 1.26 NORMAL
88 JENISHA 43     F NO NO 126/86 86 22 0.3 TRACE 0.42 GRADE 1 0.96 0.87 1.1 NORMAL
89 JEEVITHA 40     F NO NO 106/70 81 19 0.7 NIL 0.2 NORMAL 1.07 0.68 1.57 NORMAL
90 DURUVAI 49     F NO NO 108/60 73 31 0.4 NIL 0.19 NORMAL 0.87 0.64 1.35 NORMAL
91 RAMKRISHNAN 41     M NO YES 130/86 90 24 0.8 NIL 0.2 NORMAL 0.78 0.91 0.85 GRADE 1
92 MANI 50     M YES NO 110/70 83 24 0.3 NIL 0.17 NORMAL 1.14 0.67 1.7 NORMAL
93 MABEL 39     F NO NO 100/60 89 21 0.6 NIL 0.08 NORMAL 0.68 0.64 1.06 NORMAL
94 BALIAH 51     M YES NO 130/88 94 27 0.7 NIL 0.23 NORMAL 0.86 0.93 0.92 GRADE 1
95 KAVUNDAR 40     M YES NO 100/70 95 27 0.4 NIL 12 NORMAL 1.2 0.68 1.76 NORMAL
96 ARUMUGAM 45     M NO NO 132/86 97 28 0.7 NIL 0.27 NORMAL 0.94 0.68 1.38 NORMAL
97 GEETHA 46     F NO NO 128/82 82 23 0.4 NIL 0.16 NORMAL 0.86 0.57 1.5 NORMAL
98 RAHUL 36     M YES YES 110/78 96 33 0.6 NIL 0.08 NORMAL 0.98 0.76 1.28 NORMAL
99 NIRANJAN 42     M YES YES 122/84 104 36 0.7 NIL 0.16 NORMAL 1.13 0.53 2.13 NORMAL
100 ANUSHA 44     F NO NO 132/86 110 26 0.7 NIL 0.22 NORMAL 0.68 0.46 1.47 NORMAL
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ANNEXURE 3 
KEY TO MASTER CHART: 
SEX:  Male and Female 
SMOKING:     Yes or NO 
ALCOHOL CONSUMPTION:      Yes or No 
BLOOD PRESSURE:     <120/80mmHg – normotensive individuals 
                              120-139/80-89mmHg – prehypertensive individuals 
URINE ALBUMIN:     Dipstick method. Reported as follows: Trace , 1+                                    
2+, 3+ and 4+ 
URINE ALBUMIN CREATININE RATIO:  <0.3 – normal ,                                 
>0.3- microalbuminuria 
FUNDUS EXAMINATION:      Normal or Grade I to Grade IV 
hypertensive retinopathy. 
DIASTOLIC DYSFUNCION:   E/A ratio > 1 – normal                                  
E/A ratio <1 Grade I diastolic dysfunction 
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ANNEXURE 4 
ABBREVIATIONS 
NHANES    - The National Health And Nutrition Examination Survey 
NCHS         - National Center for Health Statistics   
CDC           - Center for Disease Control and Prevention 
BP              - Blood Pressure 
CO             - Cardiac Output 
HR             - Heart Rate 
SV             - Stroke Volume 
JGA           - Juxta Glomerular Apparatus 
RAAS        - Renin Angiotensin Aldosterone System 
ACE          - Angiotensin Converting Enzyme 
ACR          - Albumin Creatinine Ratio 
DASH       - Dietary Approach to Stop Hypertension 
TROPHY - Trial Of Preventing Hypertension 
